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ABSTRACT
Kulkarni Kashmira Ph.D., Biomedical Sciences Ph.D. Program, Department of
Neurosciences, Cell Biology and Physiology, Wright State University, 2009. HIF-1α: a
master regulator of trophoblast differentiation and placental development.

Early embryonic development occurs under low oxygen levels. The placenta is
an organ transiently formed during pregnancy and plays a crucial role during
development of the embryo. Alterations in the placental structure or function have been
associated with the pathologies such as preeclampsia in humans.

In mammals, the

hypoxia inducible factor (HIF) transcription factors have been identified as the major
regulators of cellular responses in low oxygen. In the current study, we investigated the
effects of low oxygen on the differentiation of trophoblast stem cells, lineage committed
trophoblast giant cells and labyrinthine lineage-committed cells.

We examined the

effects of an oxygen-insensitive form of HIF-1α on the differentiation of lineagecommitted trophoblast giant cells. Using a novel lentivirus–mediated, placental-specific
gene expression strategy, we investigated the effect of prolonged HIF-1α on placental
and embryonic development in vivo.

Our studies suggest that low oxygen inhibits

differentiation of trophoblast cells and affects several placental lineages. The expression
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of the oxygen-insensitive form of HIF-1α inhibited the molecular, morphological and
functional differentiation of trophoblast giant cells. Placental specific expression of the
oxygen-insensitive form of HIF-1α, also led to significant alterations in placental
morphology that mimic the pathology of two pregnancy-related conditions in humans,
preeclampsia and intrauterine growth restriction (IUGR). Our studies show that HIF-1α
is a master regulator of trophoblast differentiation and placental development.

iv

TABLE OF CONTENTS

BACKGROUND……………………………………………………………...….1
Early embryonic development…………………………………………….1
Placental development…………………………………………………….4
Trophoblasts and Differentiation………………………………………….7
Hypoxia inducible factors………………………………………………..11
Hypoxia inducible factors and Development…………………………….20
Trophoblasts, Low oxygen and HIFs…………………………………….21
HIFs in placental pathophysiology………………………………………22
Previous studies on HIF regulation in vivo………………………………24
Rationale and Hypothesis………………………………………………..26
Significance……………………………………………………………....27
MATERIAL AND METHODS………………………………………………..29
RESULTS……………………………………………………………………….45
DISCUSSION……………………………………………………………….....103
FUTURE STUDIES…………………………………………………………...120

v

REFERENCES………………………………………………………………...124
APPENDIX…………………………………………………………………….150

vi

LIST OF FIGURES

Figure 1.

Cell populations within blastocysts…………………………………….2

Figure 2.

Schematic representation of rodent placenta……………………………5

Figure 3.

Trophoblast cell lineages and their markers…………………………….9

Figure 4.

Schematic representation of the hypoxia inducible factor
(HIF) family. ………………………………..…………………………...12

Figure 5.

Schematic representation of the HIF life cycle in
abundant oxygen. ………………………………..………………………15

Figure 6.

Schematic representation of the HIF life cycle in low oxygen..………...18

Figure 7.

Low oxygen inhibits downregulation of the trophoblast stem marker,
inhibitor of differentiation 2 (Id2), in Trophoblast stem cells (TS3.5),
labyrinthine SM-10 cells and trophoblast giant Rcho-1 cells..…………..47

vii

Figure 8.

Low oxygen stabilizes hypoxia inducible factor-1 alpha (HIF-1α) in
Trophoblast stem cells (TS3.5), labyrinthine SM-10 cells and trophoblast
giant Rcho-1 cells. ………………………………..…………………..…50

Figure 9.

Low oxygen induces HIF-1α activity in Trophoblast stem cells (TS3.5),
labyrinthine SM-10 cells and trophoblast giant Rcho-1 cells..…………..52

Figure 10.

Confirmation of pEGFP-N1 clones..……………………………………56

Figure 11.

Confirmation of HIF-1α-3XSDM clones.………………………………59

Figure 12.

Prolonged expression of HIF-1α protein does not affect lineage
commitment of Rcho-1 trophoblast giant cells.………………………….62

Figure 13.

Prolonged HIF-1α expression inhibits molecular differentiation of Rcho-1
trophoblast giant cells.…………………………….. ………………….64

Figure 14.

Prolonged HIF-1α expression inhibits functional differentiation of Rcho-1
trophoblast giant cells. …………………………………………………..68

Figure 15.

Prolonged HIF-1α expression inhibits morphological differentiation of
Rcho-1 trophoblast giant cells. ………………………………………71

Figure 16.

Prolonged HIF-1α expression inhibits morphological differentiation of
Rcho-1 trophoblast giant cells. …………………………………………73

Figure 17.

Establishment of embryo microdrop cultures. …………………………77

Figure 18.

Uterine embryo transfer. ……………………………………………….79

viii

Figure 19.

Trophoblast specific GFP expression is observed in blastocysts infected
with pLv-[GFP]-V5 virus. ………………………………………………81

Figure 20.

Blastocysts infected with pLv-[GFP]-V5 virus exhibit placental-specific
GFP expression. …………………………………………………….....83

Figure 21.

Placentas exhibiting GFP expression, exhibit positive staining for V5
epitope tag. ………………………………………………………………85

Figure 22.

HIF-1α-3XSDM gene was cloned into Lentiviral vector. ………………89

Figure 23.

Prolonged HIF-1a protein expression affects placental and embryonic
development in vivo………………………..…………………………..91

Figure 24.

Immunocytochemical analysis of V5 staining in embryos infected with
pLv-[CA- HIF-1α]- V5……………………………………………….…93

Figure 25.

Immunocytochemical analysis of placentas infected with pLv-[CA- HIF1α]-V5 confirm HIF-1α overexpression.………………………………..95

Figure 26.

Prolonged HIF-1α protein expression alters placental morphology…….99

Figure 27.

Prolonged HIF-1α protein expression affects differentiation and
distribution of labyrinthine cells, spongiotrophoblast cells, trophoblast
giant cells and endothelial cells in the placenta in vivo ..………………101

ix

LIST OF TABLES

Table 1.

PCR primer sequences…………………………………………………35

x

Background

Early embryonic development
Embryonic development begins with the fertilization of the ovum.

As

development proceeds, the fertilized ovum progresses from a single cell to a morula (1664 –cell stage) through multiple rounds of cellular division (1-3). The morula undergoes
a compaction phase, and further forms a hollow ball of cells known as the blastocyst.
The blastocyst is composed of 64-128 cells. The early embryo at the blastocyst stage
consists of two distinct cell populations, the inner cellular population that contributes to
the formation of the embryo proper is know as the inner cell mass (ICM), while the outer
layer is known as the trophectoderm and forms the placenta (Fig. 1). The ICM consists of
embryonic stem (ES) cells capable of differentiating into the various cell types that form
the baby. Trophoblast stem (TS) cells, which form the trophectoderm, differentiate to
form all the cell types found in the fully developed, functional placenta (4,5). At this
stage, the blastocyst is contained within a tough covering known as the zona pellucida.
As pregnancy proceeds, the mature blastocyst hatches out of the zona pellucida, and
attaches to the maternal decidua through a process known as implantation.
trophoblast cells, which contribute to placental formation, act as a barrier between the
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Figure 1: Cell populations within blastocysts.
A 3.5-day post coitum (d.p.c.) embryonic stage is known as the Blastocyst. It consists of
64- 128 cells. Two predominant cell populations have been identified in the blastocyst.
The inner cell population is known as the inner cell mass (ICM) consists of the
embryonic stem (ES) cells and forms the embryo proper (yellow). The outer single cell
layer is known as the trophoblast cell layer it consists of the trophoblast stem (TS) cells
and forms the placenta (blue).
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maternal and the fetal tissues, and provide the developing fetus with nutrition and
protection from immunologic attack (6,7).

Placental development
The placenta is an important organ formed transiently during development in all
eutherian organisms and helps attach the embryo to its mother through a process known
as implantation (5,8-10). Appropriate placentation is essential for the maintenance of a
healthy pregnancy. Studies have identified analogous cell types between the human and
rodent placenta. This has lead to the use of the rodent placenta and placental cells as a
model system to study processes and development of the human placenta (1,7,11). The
rodent placenta has three distinct layers, each performing a unique role in the
maintenance of a normal pregnancy (Fig. 2). The innermost layer of the placenta in close
contact with the embryo is known as the labyrinthine layer. The labyrinthine layer is
responsible for the transport of food and waste between the mother and the developing
embryo. The intermediate spongiotrophoblast layer secretes hormones that help maintain
pregnancy and regulate maternal-fetal exchange. The outermost layer of placenta closest
to the mother is composed of giant trophoblast cells. Giant cells are responsible for the
invasion and implantation of the fetus into the maternal decidua (6,7,12-14).

The

inability of the placenta to functionally differentiate and completely implant into the
mother has severe consequences for both the mother as well as the developing fetus (15).

4

Figure 2: Schematic representation of the rodent placenta.
The rodent placenta consists of three distinct layers. The outer most layer of the placenta
closest to the mother is know as the trophoblast giant cell layer (green), the intermediate
layer consists of spongiotrophoblast cells (blue) and the inner-most layer closest to the
embryo is known as the labyrinthine layer (yellow).
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Trophoblasts and Differentiation
One of the key processes associated with the development of a multicellular
organism is the formation of multiple organ systems. Each organ system is composed of
unique cell types devoted to performing a distinct function.

The process of

differentiation is responsible for the formation of specialized cell types. Differentiation is
a process of sequential change within a cell. The process of differentiation converts a
highly proliferative stem cell, capable of giving rise to multiple cell types, into a
differentiated cell type that performs a specialized function, is locked in the G0 phase, and
incapable of further division (16,17). In the case of the rodent placenta, for instance the
proliferative trophoblast stem (TS) cells give rise to three distinct cell types the
labyrinthine trophoblasts, spongiotrophoblasts, and the giant trophoblasts upon
differentiation in vivo. Appropriate differentiation of the various embryonic cell types
within the ICM and trophectoderm is essential for a successful pregnancy (15).
In mice, each trophoblast subtype is identified by the expression of specific
markers, which are unique to a particular lineage. The trophoblast stem (TS) cells are
identified by the expression of Caudal type homeobox transcription factor 2 (Cdx2) while
the cells that form the ICM express high levels of homeobox transcription factors Oct4
and Nanog (18-21). Differentiation of the trophoblast cells leads to the formation of the
three predominant trophoblast cell lineages. The first cell type distinguished from TS
cells is the primary trophoblast giant cells. These cells are the first lineage-determined
cell type and are believed to be the initiators of the process of implantation (22,23). As
the TS cells differentiate, another distinct population of cells arises know as the
spongiotrophoblast cells. The spongiotrophoblast cells are believed to act as “stem-like
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cells” which have the potential to give rise to a second wave of giant cells known as the
secondary giant cells.

The primary and secondary trophoblast giant cells exhibit

transcription factor Heart and neural crest derivatives expressed 1 (Hand-1) early during
development, whereas the expression of placental lactogen I and II (Pl1 and Pl2) are
observed throughout development (14,24-27).

The spongiotrophoblast cells are

identified by the expression of transcription factor trophoblast specific protein a
(Tpbpa/4311). The labyrinthine cells are identified by the expression of labyrinthine
specific markers such as Tec kinase (Tec), and Glial cell missing 1 (Gcm-1) among other
markers (Fig. 3)(11,13,14,28,29). With the initiation of differentiation, the cells become
more restricted in their ability to form multiple cell types. Undifferentiated trophoblast
cells have been identified by the expression of the transcription factor inhibitor of
differentiation 2 or the inhibitor of DNA binding 2 (Id2)(12,13,30). Decreases in the
levels of Id2 are consistent with the induction of differentiation in TS cells. Since the
early embryo resides in particularly low oxygen conditions the role of low oxygen and
low oxygen-induced HIFs in orchestrating the process of differentiation has recently been
suggested.

8

Figure 3: Trophoblast cell lineages and their markers.
The trophoblast stem cells (TS) form the outer layer of the blastocysts, and are capable of
differentiating

into

the

three

placental

lineages,

trophoblast

giant

cells,

spongiotrophoblast cells and labyrinthine cells. The TS3.5 mouse cell line is a model for
TS cell studies. The Rcho-1 rat cell line is a model for trophoblast giant cell studies and
exhibits the expression of markers Pl1 and Hand-1. The spongiotrophoblast cells are
identified by the expression of the Tpbpa/ 4311 marker. The HRP-1 and SM-10 serve as
models for labyrinthine cells and exhibit markers Tfeb, Tec and Esx-1.
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Hypoxia inducible factors
Before implantation, the fertilized embryo is present in a maternal environment at
low levels of oxygen. Before implantation, the developing embryo is exposed to ~2-3%
oxygen, whereas the normal arterial oxygen level found in the endometrium is ~8-13%,
hence conception and early development of the embryo occurs in a low oxygen or
hypoxic environment (31-34). Hypoxia refers to a condition where the presence of
oxygen is lower than the “physiological normal” levels of oxygen, which may vary
between various tissue types. The level of oxygen considered hypoxic depends on the
tissue or system under study. Hence, although the embryo is exposed to levels of oxygen
that are much lower than the maternal arterial levels, these levels are “normal” for the
developing embryo before implantation.

The term low oxygen rather than hypoxia

appropriately define the oxygen conditions in the embryonic environment.
In mammals, the effects of hypoxia or low levels of oxygen are mediated by a
family of transcription factors known as the hypoxia inducible factors (HIFs). HIFs are
heterodimeric proteins composed of an α and a β subunit. Dimerization of the α and the
β subunit is essential for a functional transcriptional factor. HIFs belong to the β helixloop-helix family of transcription factors (35, 36). The β subunit- HIF-β is also known as
the aryl hydrocarbon receptor nuclear translocator (ARNT1).

It is constitutively

expressed in all levels of oxygen and is ubiquitously present in all cell types. Two more
isoforms, ARNT2 and ARNT3, have been identified; however these exhibit tissuespecific expression (37,38). Three isoforms of the α subunit have been identified HIF-
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Figure 4: Schematic representation of the hypoxia inducible factor (HIF) family.
Hypoxia inducible factors are heterodimeric transcriptional factors. HIFs consist of a
constitutively expressed beta (β) subunit, and an oxygen sensitive alpha (α) subunit.
HIF-1α and HIF-2α are the two predominant alpha subunits while the Aryl hydrocarbon
receptor nuclear translocator (ARNT) or HIF-1β is the predominant beta subunit. The α
and β subunits contain beta-helix-loop-helix (bHLH) domain, Per-Arnt-Sim (PAS)
domain and transactivation domains (TAD). Dimerization of the α and the β subunit is
essential for a functional transcription factor.
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1α, HIF-2α and HIF-3α (Fig. 4). HIF-1α and HIF-2α have been well characterized,
however the function of HIF-3α has not been well established (39, 40). While HIF-1α
mRNA is ubiquitously present, HIF-2α and HIF-3α show a more restricted pattern of
expression (36,40,41). The HIF-1 β protein consists of a basic helix-loop-helix (bHLH)
domain, two PER-ARNT-SIM domains (PAS1 and PAS2) and one transactivation
domain (TAD). The HIF-1α protein in addition to the bHLH domain and two PAS
domains, (PAS1 and PAS2) contains an additional C-terminal transactivation domain
(CTAD) and an N-terminal transactivation domain (NTAD). An oxygen dependent
degradation (ODD) domain lies within the CTAD and is extremely critical for the rapid
degradation of HIF-α in abundant oxygen. Both HIF-1α and HIF-2α exhibit a high
sequence similarity in the bHLH and PAS domains, whereas the transactivation domains
show little similarity, however the ODD region is highly similar between the two proteins
(35,42). While the β subunit is constitutively expressed, rapid degradation of the α
subunit protein is observed in the presence of oxygen (Fig. 5). The oxygen dependent
degradation of the HIFs is attributed to the oxygen-dependent degradation domain (ODD)
located at the C terminus of the α subunit. In the presence of high levels of oxygen (>8%
oxygen), critical HIF-degradation enzymes are activated. The predominant HIF-α
degradation enzymes activated by presence of oxygen (>8% oxygen) belong to the prolyl
hydroxylase domain (PHD) family of proteins. Currently three PHD isoforms have been
identified PHD1, PHD2 and PHD3. In the presence of oxygen, PHD catalyzes the
hydroxylation of key proline residues (p402 and p564) within the ODD of HIF-α
(35,39,40). In addition to oxygen, PHDs require iron (Fe) and 2-oxoglutarate for HIF
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Figure 5: Schematic representation of the HIF life cycle in abundant oxygen.
The HIF-1α subunit is degraded in abundant oxygen. Oxygen sensing prolyl hydroxylase
domain enzymes (PHD) in the presence of abundant oxygen and Fe, hydroxylate key
proline residues within the oxygen dependent degradation domain of the HIF-1α subunit.
Hydryoxylated α subunit is recognized by the Von Hipple Lindau (VHL) protein, an E3
ligase. VHL ubiquitinates hydroxylated subunits, which are degraded via the proteasome
degradation pathway. Half-life of the HIF-1α subunit is ~5 minutes in abundant oxygen.
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hydroxylation. Hydroxylated proline residues are recognized by the Von Hipple Lindau
protein (pVHL), an E3 ligase, which mediates the polyubiquitination of hydroxylated
HIF-α. Polyubiquitinated HIF-α is degraded via the proteasomal degradation pathway
(39,40,43). Acetylation of a lysine residue (K532) within the ODD of HIF-α is also
suggested to play a role in the ARD1-mediated degradation of HIF. Besides regulation of
protein stability, the transcriptional activity of HIF is also regulated in low oxygen.
Factor inhibiting HIF (FIH), an asparaginyl hydroxylase, hydroxylates a key aspargine
residue (N803) within the C-terminal activation domain (CAD) of the α subunit. The
hydroxylation prevents recruitment of p300 and cofactors essential for HIF
transcriptional activity, thus inhibiting HIF-mediated transcription in abundant oxygen.
Strict regulation of HIF levels in abundant oxygen restricts the expression of HIFinduced gene expression (44-46).
In low oxygen, the absence of abundant molecular oxygen inhibits the activation
of PHDs, which require oxygen for hydroxylation and thus the degradation of HIF
(Fig.6). This allows for the stabilization of HIF-α, which dimerizes with HIF-β, thus
forming a transcriptionally active HIF complex, which translocates to the nucleus.
Whether HIF-α and HIF-β dimerize in the nucleus or in the cytoplasm is still unclear.
Several cofactors such as CBP/p300, SRC-1or TIF-2 are known to be associated with the
active HIF-1 transcription complex (47-49). Active HIF-1 binds a consensus sequence
5'-RCGTG-3' known as the hypoxia responsive element (HRE), within the promoter
regions of several hypoxia or low oxygen-induced genes (42,50,51). Numerous genes
involved in angiogenesis, vascular remodeling, metabolism, erythropoiesis, cell
proliferation, viability, and cell death are activated by HIF-1 under low oxygen (52,53).
17

Figure 6: Schematic representation of the HIF life cycle in low oxygen.
The HIF-1α subunit is extremely stable in low oxygen. In the absence of abundant
oxygen, oxygen sensing prolyl hydroxylase domain enzymes (PHD) are inactive, thus
allowing for stabilization of the α subunit. The α subunit dimerizes with the β subunit,
and translocates to the nucleus.

The active HIF-1 transcription factor, along with

cofactors such as CBP/p300, binds hypoxia responsive elements (HRE), a pentameric
nucleotide sequence- RCGTG within promoter regions of HIF-regulated genes, allowing
for their transcription.
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Post-translational phosphorylation and acetylation are also believed to regulate HIF-1
activity in vivo.

Hypoxia inducible factors and Development
Early development takes place under low oxygen conditions. Implantation leads
to the establishment of maternal-fetal blood supply and leads to an increase in the level of
oxygen available to the developing embryo. While low oxygen levels exhibit higher
levels of HIFs and maintain a predominantly proliferative state of cells in the developing
embryo, increasing levels of oxygen are consistent with decrease in the levels of HIFs
and the induction of differentiation in several cell types (54). In the early embryo,
contribution of the HIFs to embryonic and placental development has not been
elucidated. HIF-2 has been indicated as the major regulator of Oct4 expression in the
early blastocyst. Expression of Oct4 is essential for the maintenance of the ICM cell
population (55, 56).

Oct4 expression is abundant in the ICM or ES cells, which

contribute to the formation of the embryo; this has been supported by the finding that loss
of HIF-2 leads to defects in embryonic development; ultimately leading to embryonic
death during gestation or early after birth. However mice lacking HIF-2 do not exhibit
placental defects (57, 58).
HIF-1 on the other hand has been shown to play an important role early during
placental development and thereafter in embryonic development. Loss of HIF-1α causes
severe defects in placental formation and leads to embryonic death early during gestation.
In the developing embryo, HIF-2 plays an important role in the formation of the vascular
system. Vascular endothelial growth factor (VEGF) a HIF-1-specific target gene, is
20

known to orchestrate neovasculogenesis (59,60). Regulation of brain development, bone
morphogenesis and adipogenesis has also been attributed to HIF-1 (61, 62). HIF-1 and
HIF-2 have overlapping but not identical gene targets. Studies dissecting the role of
HIFs during early embryonic and placental development suggest that while HIF-1
regulates placental as well as embryonic development, HIF-2 regulation is strictly
limited to the embryo.

Trophoblasts, Low oxygen and HIFs
Trophoblast cells form the outermost layer of the developing blastocyst.
Trophoblast stem (TS) cells isolated from the trophoblast layer have been used as a
model to study the differentiation and functioning of trophoblast in vivo. Trophoblast
stem cells lacking Arnt (Hif-1β) or Hif-1α and Hif-2α failed to differentiate into all the
three cell types of the placenta and expressed markers for only the syncytiotrophoblast or
labyrinthine cell population. This suggests that HIFs are essential for the formation of
the trophoblast giant cell and the spongiotrophoblast lineages (58, 63).
Low oxygen has recently been identified as a determinant of trophoblast lineage
commitment in both human as well as murine cells (12, 64, 65). Culturing murine
embryos in low oxygen (2% oxygen) exhibit a significant decrease in the number and
distribution of trophoblast giant cells upon placental formation (66).

Studies on

differentiation of trophoblast giant cells suggest that low oxygen inhibits trophoblast
giant cells differentiation. Increasing the levels of oxygen relieved low oxygen-induced
inhibition of trophoblast differentiation (65).

21

HIFs in placental pathophysiology
In humans, HIF proteins are believed to play a crucial role during early placental
and embryonic development (33). Increased expression of HIF-1 and HIF-2 protein has
been observed in the normal human placenta during the first trimester, without alterations
in the mRNA levels (67-69). Implantation leads to an increase in blood flow to the
placenta, which in turn has been associated with a decrease in the levels of placental HIFs
post implantation (67).
A major pregnancy-related disorder, known as preeclampsia, has the second
highest pregnancy-related morbidity rate, and affects 5-8% of all pregnancies (70,71).
Preeclampsia is characterized by gestational hypertension and proteinuria, leading to
babies with lower birth weight. Preeclamptic symptoms appear predominantly in the late
2nd trimester and throughout the 3rd trimester in humans.

Alterations in placenta

formation have been identified as a central cause for the pathogenesis of preeclampsia.
Preeclamptic placentas exhibit shallow invasion into the maternal decidua, decreased
maternal spiral artery remodeling and poor placental vascularization (72-78).

An

increase in both protein levels as well as the DNA-bound HIF-1 protein has been
observed in preeclamptic placentas, suggesting an abnormal or prolonged presence of
transcriptionally active HIF-1 in preeclamptic placenta compared to normal placenta
(79). Although the exact cause for the increased HIF-1α levels in preeclamptic placentas
is unknown, a possible alteration or defect in the HIF-1 degradation pathways has been
suggested (79,80).
It is of note that no change in the levels of VHL protein, involved in HIF-1
degradation, was observed in preeclamptic placenta when compared with normal placenta
22

(81). Another condition that gives rise to placental pathology similar to preeclampsia is
intrauterine fetal growth restriction (IUFGR), previously know as intrauterine growth
retardation (IUGR). IUFGR and preeclamptic placenta exhibit decreased proteasomal
activity, suggesting a possible mechanism for HIF-1 stabilization in preeclamptic
placentas (82). Increased expression of HIF-1α has also been observed in placentas
obtained from women living at a higher altitude, who also exhibited an increased
incidence of decreased birth weights and preeclampsia (83, 84). Together these studies
suggest the involvement of HIF-1 in the pathogenesis of preeclampsia. It is yet to be
ascertained whether the condition occurs due to increased HIF-1 expression and
prolonged HIF-1 activity or the increased expression of HIF-1 is a result of the condition.
Animal models of preeclampsia suggest the possibility that prolonged HIF-1α
protein levels may possibly serve as a trigger for the initiation of preeclampsia. Several
animal models exist for the study of preeclampsia. An in vivo rat model generated by the
administration of soluble fms-like tyrosine kinase-1 (sFlt-1) resulted in the preeclampsia
phenotype. sFlt-1 is a direct target of HIF-1, and hence supports the role of HIF-1 in the
progression or development of preeclampsia (85). Increased sFlt-1 expression has also
been associated with preeclampsia in humans (86-88). A more recent study by Kanasaki
et al (2008) suggests that a deficiency in catechol-o-methyltransferase (COMT) and 2methoxyoestradiol (2-ME) is associated with preeclampsia (89). Comt-/- mice exhibited a
preeclampsia like phenotype, which was believed to have occurred due to the absence of
2-ME. Administration of 2-ME to Comt-/- mice resulted in the amelioration of the
preeclampsia symptoms. In vivo, 2-ME has been shown to inhibit HIF-1α (90,91). The
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absence of Comt lead to an increase in HIF-1α protein levels in the placenta, which were
dramatically decreased with administration of 2-ME (89).

Previous studies on HIF-1 regulation in vivo.
Knockout (KO) studies in animal models highlight the importance of HIFs during
development.

HIF-1α KO mice are embryo-lethal, and die early during gestation

embryonic day 10.5 (E10.5) due to failure of appropriate placenta formation. Hif-1α-/placentas failed to exhibit chorio-allantoic fusion, had severely decreased vascularization
and exhibited significantly decreased spongiotrophoblast cell number, suggesting a role
for HIFs during placental development (8,58,92-94).
HIF-2α KO mice show a high rate of embryonic lethality at day E12.5. Embryos
exhibited a failure to remodel vasculature, which resulted in severe vascular defects and
hemorrhaging, ultimately causing lethality.

The placenta, however, did not exhibit

significant alterations in structure or function, suggesting that the embryonic lethality
observed in Hif-2-/- mice was due to the failure of vascularization in the embryo (58,95).
HIF-1β (also known as ARNT) is the predominant binding partner for HIF-1α.
The dimerization of HIF-1α and HIF-1β leads to the formation of the active transcription
factor HIF-1. HIF-1β KO mice show embryonic lethality similar to HIF-1α KO (58,9698).

Embryonic lethality was observed between E9.5-10.5.

The embryonic death

observed in Arnt-/- embryos has been attributed to insufficiencies in placental formation.
These embryos exhibited significant alteration in placental morphology with defective
placental vascularization, small chorionic plate, decreased labyrinthine cavities and
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decreased spongiotrophoblast cells suggesting significant alterations in placental cell
differentiation.
Mice lacking pVHL, a protein involved in the degradation of HIF, die in utero
between E10.5-12.5 and exhibit gross deformities in both placenta as well as the embryo
formation (99). In particular, hemorrhaging, and necrotic lesion formation was observed
in the labyrinthine region of the placenta. A less severe phenotype was observed in
VHL-inactivated embryos (100). While HIF-1α and HIF-2α have been identified as its
predominant targets, pVHL regulates the expression of several other HIF-1-independent
genes involved in pathways including signaling, transcription, and cell modeling which
may play a role during early embryogenesis, thus resulting in a severe embryonic
phenotype (101).
PHD2 knockout mice represent a condition similar to low oxygen, with decreased
HIF-1 degradation, allowing for prolonged HIF-1 activity.

While Phd2-/- placentas

exhibited no significant difference in labyrinthine layer thickness, significant alterations
in spongiotrophoblast and trophoblast giant cell distribution were observed on E11.5 in
Phd2-/- placenta. In addition to placental defects observed in Phd2-/- mice, significant
defects in embryonic vasculature were also observed. Phd2-/- mice exhibit embryonic
lethality between E12.5-14.5 (102).
Whether the loss of the PHD2 led to a preeclamptic phenotype is unknown.
PHD2 regulates the expression of HIF-1 and HIF-2 in vivo (103). Two other PHD2
isoforms, PHD1 and PHD3 are also known to regulate HIF expression in vivo. Whether
HIF-1 or HIF-2 or both are involved in the embryonic lethality observed in Phd2 -/- mice
is unknown. In addition the role of PHD1 and PHD3 in regulating HIF expression in the
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absence of PHD2 is also unclear. The study while reconfirming the role of HIFs during
development, does not clearly address the effect of prolonged HIF-1α alone (103).

Rationale and Hypothesis
Appropriate differentiation of trophoblast cells is key to the process of
implantation as well as the formation of a functional placenta. Early development occurs
under low oxygen (2-3%) compared with maternal arterial oxygen (8-10%), but the low
levels of oxygen present are normal for the developing embryo. During implantation a
gradual increase in the oxygen level occurs as the trophoblasts invade maternal arteries.
Post-implantation, the embryo is exposed to oxygen levels similar to those observed in
the maternal arteries.

In mammals, HIFs are the predominant proteins involved in

response to low oxygen. An increase HIF levels is consistent with decrease in the level
of oxygen, while decrease in HIF levels is consistent with an increase in the level of
oxygen in numerous systems. While HIF-1 has been shown to play a role in proliferation
of several cell types and upregulation of HIF-1 expression has been observed in several
cancers, the role of HIF-1 in regulating differentiation is however unclear.
Previous studies from our and other labs have suggested that decrease in levels of
oxygen led to an inhibition of trophoblast cell differentiation. Studies investigating the
role of the loss of HIF-1α and HIF-1β, have shown that the absence of a functional HIF-1
transcriptional unit alters lineage commitment of trophoblast stem (TS) cells in vitro.
Recent studies investigating the role of HIF-1 in development have highlighted the
importance of HIF regulation during early development. Previous studies have suggested
deregulation of HIF-1 expression resulted in placental and embryonic defects, however,
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the effect of prolonged HIF-1 expression on the differentiation of trophoblast cells and
placental development has not yet been investigated. We hypothesize, that prolonged
HIF-1α expression inhibits trophoblast cell differentiation and placental development
in vivo.
In Aim1 we examined the effect of low oxygen (3%) on the differentiation of trophoblast
stem cells, trophoblast giant cell lineage committed Rcho-1 cells and labyrinthine cell
lineage committed SM-10 cells.
In Aim 2 analyzed the effect of constitutively-active HIF-1α on the differentiation of
lineage committed Rcho-1 cells.
Finally in Aim 3 we examined the effects of prolonged expression of an oxygen
insensitive form of HIF-1 in the placenta, on embryonic and placental development using
a novel lentiviral-placental-specific gene targeting based strategy in vivo.

Significance
Abnormal placental development has severe consequences for both mother as
well as the baby. Trophoblast cells, which contribute to placental formation, maintain an
undifferentiated state in low oxygen and are believed to differentiate with an increase in
oxygen levels. Our study suggests that HIF-1 is the master regulator of low oxygen
responses in trophoblast cells and an increased or prolonged expression of HIF-1 is
sufficient to inhibit trophoblast differentiation in ambient oxygen, thus mimicking lowoxygen-induced inhibition of trophoblast differentiation. In the trophoblast cells, the
effect of low oxygen is not specific to one lineage.
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Insufficiencies in placenta formation have been associated with two pregnancyrelated conditions, preeclampsia and IUFGR. While several studies have suggested the
role of HIF-1 in the pathogenesis of these conditions, this study is the first to show the
direct involvement of HIF-1 in the generation of placental phenotype in mice similar to
that observed in human preeclampsia.
Finally, the use of lentivirus for placental specific expression of genes provides a
novel tool for assessing the importance of the placenta during development, and provides
for a convenient method to investigate the effect of placental specific gene expression on
the developing embryo. The use of lentiviral gene targeting can drastically decrease the
time to generate genetically modified animal models compared to traditional gene
targeting strategies. In addition this tool allows for the generation of knockout animal
models through the use of short hairpin RNA (shRNA) technology, as well as allows for
the investigation of prolonged gene expression during early development and throughout
adult life.
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Materials and Methods

Materials:
The mouse trophoblast stem cell line, TS3.5/Rosa26, was a kind gift from Dr. James
Cross, University of Calgary, Canada (104,105). The Rcho-1 rat trophoblast cell line was
a kind gift of Dr. Michael Soares, Kansas University Medical Center (KUMC), Kansas
City, Kansas. The Cos7 cell line was purchased from ATCC. The Mouse SM-10 cell line
was kindly provided by Dr. Joan Hunt, Kansas University Medical Center (KUMC),
Kansas City, Kansas (13,106). Primary mouse embryonic fibroblast (pMEF) cells were
purchased from Stem Cell Technology, Inc. The 293FT cell line was purchased from
Invitrogen Corp.

RPMI 1640 and DMEM cell culture media was purchased from

Mediatech, Inc. KSOM and M2 blastocyst culture media were obtained form Millipore
and Sigma, respectively. NCTC 135 cell culture media, sodium pyruvate, heparin, G418
antibiotic, Hoechst dye, CellLytic NuCLEAR Extraction Kit, Acid tyrodes and embryo
culture grade mineral oil were obtained from Sigma. Human recombinant Fibroblast
Growth Factor-4 (FGF-4) was obtained from Peprotech Inc.
solution was obtained from Gibco.

Antibiotic-antimycotic

Primers were synthesized by Integrated DNA
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technology. DNA marker (100bp) was purchased from Minnesota Molecular. GoTaq
green master mix, random hexameric primers, and dNTPs were purchased from Promega.
Reverse transcriptase was purchased from Stratagene.

All restriction enzymes and T4

DNA ligase were purchased from New England Biolabs. Primary rabbit polyclonal
antibody that recognizes CSH1 (PL1) was a generous gift of Dr. Michael Soares (107).
Primary polyclonal anti-HIF-1α antibody (NB100-499) was obtained from Novus
Biologicals. Antibody recognizing V5-topo epitope (AB3792) was purchased from
Millipore. Primary monoclonal antibody that recognizes palladin was a generous gift of
Dr. Carol Otey, University of North Carolina at Chapel Hill (108).

The monoclonal

antibody that recognizes pan-actin was a gift of Dr. James Lessard, Cincinnati Children’s
Hospital Medical Center, Cincinnati, Ohio (109). Secondary antibodies were purchased
from Promega (anti-mouse). Rhodamine-conjugated phalloidin (R415), Alexafluor 594
secondary antibody for immunocytochemistry and FluorSave mounting media were
obtained from Calbiochem and Molecular Probes, respectively. A plasmid encoding for a
constitutively stable form of HIF-1alpha for the generation of HIF-1α-3xSDM clones,
was a kind gift from Dr. Christine Warnecke, Universität Erlangen-Nürnberg, Germany
(110). The PGK1-HRE-luciferase reporter plasmid containing 6 copies of the HRE
consensus sequence from the promoter of the phsophoglycerate kinase–1 (PGK1) gene
upstream of a firefly luciferase gene in the pGL3 vector was a kind gift from Dr. Peter
Ratcliffe, University of Oxford, England (111). Metafectene transfection reagent was
purchased from Biontex. The Dual Luciferase Reporter Assay Kit was obtained from
Promega. PEG-it, virus precipitation solution was obtained from System Biosciences.
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Methods:
Cell culture:
Primary mouse embryonic fibroblast (PMEF) cells were cultured in Dulbecco’s
modified (DMEM/L-glutamine), 10% Fetal bovine serum (FBS), 100 µM ßmercaptoethanol, 1% antibiotic-antimycotic. Cells were harvested for passaging every
second day by Trypsin-EDTA (0.25% trypsin in 1 mM EDTA) treatment. To collect
PMEF conditioned media, cells were plated at a density of 2 x 105 cells/ml. At 72 hrs post
plating fresh media was added. Every 72 hrs post media change, conditioned media was
harvested, and replaced with fresh media. Conditioned media was filter sterilized and
stored in aliquots at -20oC until further use.
TS3.5 Trophoblast stem cells were cultured in “ stem” media containing 70%
PMEF conditioned media and 30% TS base media (RPMI1640/L-glutamine, 20% FBS,
100 µM ß-mercaptoethanol, 1mM sodium pyruvate, 1% antibiotic- antimycotic) and was
supplemented with hrFGF4 (25 ng/ml) and heparin (1 µg/ml). Cells were harvested for
passaging every second day by Trypsin-EDTA (0.25% trypsin in 1mM EDTA) treatment.
For differentiation assays, cells were seeded at a density of 1x105 cell/plate in p60 plates.
The following day, media was replaced with fresh media containing FGF4 and heparin,
for maintaining cells in the stem cell state. For induction of differentiation, FGF4 and
heparin was withdrawn from media. Differentiation was induced for 96 hrs.
SM-10 cells The mouse SM10 cell line was maintained in RPMI1640/L-glutamine
medium supplemented with 1 mM sodium pyruvate, 50 µM 2ß-mercaptoethanol, 1%
antibiotic-antimycotic, and 10% fetal bovine serum (FBS). Cells were passaged at
subconfluency with Trypsin-EDTA (0.25 % trypsin in 1mM EDTA) treatment (106). For
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differentiation experiments, cells were seeded at a density of 1x105 cell/plate in p60
plates. The following day, the media was replaced with fresh media containing 5 ng/ml
TGF-ß for differentiation, while cells maintained as stem were treated with vehicle (4
mM HCl, 0.1% v/v bovine serum albumin (BSA) in 1XPBS (137 mM NaCl, 3.9 mM
KCl, 15 mM Na2HPO 4, and 1.8 mM KH2PO4)) for 72hrs.
Rcho-1 cells were maintained in “stem cell” media containing RPMI 1640 with Lglutamine supplemented with 20% FBS, 50 μM 2-mercaptoethanol, 1 mM sodium
pyruvate, 10mM HEPES, and 1% antibiotic-antimycotic and passaged at subconfluency
by Trypsin-EDTA (0.25% trypsin in 1mM EDTA) treatment.

For differentiation

experiments, cells were cultured for 3 days until approximately 75% confluent in stem
cell. Media was changed to differentiation media (NCTC 135 supplemented with 26 mM
sodium bicarbonate, 50 µM 2-mercaptoethanol, 1 mM sodium pyruvate, and antibioticantimycotic) supplemented with 10% horse serum. Differentiation was induced for 7
days, and differentiation media was replenished every other day during the differentiation
time course.
For subculturing, all cells were maintained at 37oC in 95 % O2 and 5% CO2 (112).
For hypoxic experiments, cells were incubated in a hypoxia incubator (Hypoxic Glove
Box, Coy Laboratory Products, Inc.). Oxygen concentration was maintained at 3% by an
oxygen regulator and supplemented with 5 % carbon dioxide and balanced by nitrogen at
37˚C. Reagents used in hypoxic experiments were pre-equilibrated in the chamber for 30
minutes prior to use. Control samples were maintained at 21 % oxygen/5 % carbon
dioxide at 37˚C.
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293 FT cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM)
supplemented with 10 % FBS, and 1% antibiotic-antimycotic, 1 % 10mM MEM NonEssential Amino Acids (Gibco) 1 % 100mM Sodium Pyruvate and 1 % 200mM LGlutamine. Cells were harvested for passaging every 2nd day by Trypsin-EDTA (0.25 %
trypsin in 1 mM EDTA) treatment. Cells were cultured at 37o C in 95 % O2 and 5 %
CO2.

Generation of HIF-1α- 3XSDM expressing clones:
Rcho-1 cells were plated at a density of 1x105 cells/ml. Twenty-four hours post
seeding, cells were transfected with either 6 μg of pEGFP-N1 plasmid or 6 μg of HIF-1α3xSDM plasmid using 6 μl of Metafectene transfection reagent in serum and antibioticfree media. Transfections were applied for 24 hours in antibiotic free media, after which
media was changed to the serum-containing media. Forty-eight hours post transfection,
cells were placed under selection with media containing 0.75 mg/ml G418 antibiotic.
Cells were selected in G418 for 7 days with media changes containing fresh antibiotic
every other day. Stable clones expressing HIF-1α-3xSDM or GFP were isolated by
limiting dilution method and were maintained under antibiotic selection. GFP-expressing
clones were confirmed by fluorescence microscopy, and HIF-1α-3xSDM-expressing
clones were confirmed by genomic PCR analysis, Western blot analysis, and luciferase
reporter assays.

33

Genomic polymerase chain reaction:
Genomic DNA was isolated from clones stably expressing GFP or HIF-1α3xSDM, using DNeasy® tissue kit (Qiagen) according to the manufacturer’s instructions.
Genomic Polymerase chain reaction (genomic PCR) analysis was performed using 1 μl
of genomic DNA 2 μl of 200 nM CMV forward primer, 200 nM Hif-1α reverse primer, 2
μl of 40 nM Beta actin forward primer, 40 nM Beta Actin reverse primer, and 12.5 μl 2X
GoTaq GreenTM (Promega) mix. Genomic PCR was performed as follows: a 5 minute
denaturation step at 94ºC, 40 cycles of 1 minute at 94ºC, 1 minute of annealing at 60oC,
and 1 minute extension at 72ºC, followed by a final extension for 15 minutes at 72ºC.
Genomic PCR products were separated on a 0.8 % agarose gel, and were visualized using
ethidium bromide and UV light. Images were captured using a LAS-3000 Imager (Fuji)
and Image Reader software.

Reverse transcriptase polymerase chain reaction (RT-PCR):
Total cellular RNA was extracted from stem and differentiated trophoblast stem
(TS3.5), Labyrinthine (SM-10) and trophoblast giant cells (Rcho-1) using RNeasy® RNA
Extraction Kit (Qiagen) per manufacturer’s instructions.

Isolated RNA was further

treated with DNase I treatment to eliminate any contaminant DNA. Complementary
DNA (cDNA) synthesis was performed by reverse transcription using 5 μg RNA, 1 μg
random hexamer primers, 100 μM dNTPs, and 50 units Stratascript Reverse
Transcriptase. Total cDNA was used as a template for polymerase chain reaction for
analysis of inhibitor of differentiation 2 (Id2), Tec, Tbpba/4311 and Hand-1 expression.
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GENE

SEQUENCE

Id2 Forward

5’ tctgagcttatgtcgaatgatagc 3’

Id2 Reverse

5’ cacagcattcagtaggctcgtgtc 3’

Beta Actin Forward

5’ atcgtgggccgccctaggca 3’

Beta Actin Reverse

5’ tggccttagggttcagagggg 3’

Hand-1 Forward

5’ gcgcctggctaccagttaca 3’

Hand-1 Reverse

5’ agcaacgccttccctctagg 3’

Tpbpa/4311 Forward

5’ caggtacttgagacatgactc 3’

Tpbpa/4311 Reverse

5’ ggcagagatttcttagacaatg 3’

Tec Forward

5’ ataagaaagaccctgcctccc 3’

Tec Forward

5’ aagcctcaccactccaaaca 3’

CMV-Forward

5’ aatgggcgtggataggcggtttga 3’

HIF-1α Reverse

5’ cgctgrgtgtttwgttctt 3’

TM

SIZE

REF

62oC

497 bp

(113)

55-62oC

243 bp

(114)

64oC

746 bp

(115)

58oC

458 bp

(96)

60oC

663 bp

60oC

835 bp

@

@

Table 1: PCR primer sequences
Primers were used for RT-PCR analysis of trophoblast lineages and genomic-PCR
analysis of HIF-1 clones are shown along with their amplification temperatures (TM),
amplicon size (Size) and references (Ref). @ Primer sequences were identified using the
NCBI MCVector software. r = G or A and w = T or A.
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Analysis was performed using 5 μl of cDNA, 2 μl of 200 nM Id2 forward primer, 200
nM Id2 reverse primer, 2 μl of 40 nM Beta actin forward primer, 40 nM Beta Actin
reverse primer, and 12.5 μl of 2X GoTaq GreenTM (Promega) mix (Table I). PCR was
performed as follows: a 5 minute denaturation step at 94ºC, 40 cycles of 1 minute at
94ºC, 1 minute of annealing at 62oC for Id2 analysis, and 1 minute extension at 72ºC,
followed by a final extension for 15 minutes at 72ºC. PCR products were visualized after
separation on 0.8% agarose gels. PCR products were visualized with ethidium bromide
and UV light, and images were captured using a LAS-3000 Imager (Fuji) and Image
Reader software.

Protein extraction:
Nuclear and cytoplasmic extracts (used for HIF-1α and CSH1 protein analysis,
respectively) were isolated using the CellLytic NuCLEAR Extraction Kit per the
manufacturer’s instructions. Briefly, stem and differentiated cells were scraped and
collected in chilled PBS under the specified oxygen condition. Cells were lysed using the
hypotonic lysis solution. Nuclear and cytoplasmic lysates were isolated by treatment
with specified solutions and differential centrifugation. Proteins were used for Western
blot analysis or stored at -80oC until further use. For palladin protein isolation, stem and
differentiated cells were collected in equal volumes of boiling Laemmli Reducing Buffer
and resolved on SDS-PAGE (65,116,117).
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Protein determination:
Extracts were collected as described above. Protein concentrations were
determined using the Bradford method. Extract (2 μl) was added to 1ml Bradford reagent
containing 18 μl water. Samples were analyzed spectrophotometrically at 595 nm. The
concentration of protein in each sample was determined using a Bovine serum albumin
(BSA) standard protein curve (118).

SDS-PAGE:
Nuclear extracts (12.5-50 μg protein) and cytoplasmic extracts (100 μg) were
reduced using 1x reducing sample buffer (62.5 uM Tris pH 6.8, 2 % SDS, 12.5 %
glycerol, 2.5 % Beta- mercaptoethanol and 0.1 % of 2.5 % bromophenol blue in ethanol
(116). Samples were boiled at 95oC for 10 minutes and separated on 8 %-10 % SDSpolyacrylamide gel. Precision plus protein standard dual colored markers were used to
determine the molecular weights (BioRad).

Western blot analysis:
Proteins separated by SDS-PAGE electrophoresis were transferred to PVDF
(polyvinylidene fluoride) membrane in transfer buffer (25 mM Tris pH 8.0, 192 mM
glycine and 20% methanol overnight at 100 mA constant current (12,117). Ponceau S
staining was used to confirm protein transfer.

The membrane was incubated with

blocking buffer (5% Non- fat milk, 60 mM Tris base, 204 mM NaCl, 0.025% Tween 20,
pH 7.4) for 1hr at room temperature on a rocking platform. Subsequently, the blot was
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incubated with primary antibody at 4oC overnight or 1hr at room temperature on a rocker.
The membrane was washed three times with 1x PBS containing 0.05% Tween 20, and
was incubated with secondary antibody for 1hr while rocking. After 1hr incubation, the
membrane was washed three times with 0.05% Tween 20 in 1XPBS (12,117). Specific
protein was identified with ECL chemiluminiscence reagent (Amersham).

Luciferase assay:
To determine Hypoxia Response Element (HRE) reporter activity in differentiated
TS3.5, SM-10 and Rcho-1 cells, the cells were transfected with 1μg PGK1-HRE
luciferase reporter plasmid and 5µl Metafectene reagent as previously described. Media
was changed 18 hrs post transfection, and cells were split into two plates with 1x105 cells
each. Twenty four hours post seeding, differentiation was induced in 21 % oxygen or 3
% oxygen. On the final day of differentiation, luciferase reporter activity was determined
by using the Dual Luciferase Assay system (Promega) according to the manufacturer’s
protocol. Results show the fold-increase in HRE activity in samples cultured in hypoxia
relative to the activity in corresponding controls (at 21 % oxygen) from the same
transfections.
To determine Hypoxia Response Element (HRE) reporter activity in differentiated
HIF-1α-3xSDM or GFP-expressing clones, cells were transfected with 1 μg PGK1-HRE
luciferase reporter plasmid and 0.2 μg pRLSV40-promoter constitutive reporter plasmid
as described above. Media was changed at 18hrs post transfection. Twenty-four hours
post media, luciferase reporter activity was determined as per manufacturer’s
instructions. In each sample, HRE promoter activity results were normalized to
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constitutive CMV promoter activity to control for transfection efficiency. Results show
the fold-increase in HRE reporter activity in HIF-1α-3xSDM-expressing clones
compared to GFP-expressing clones (set to a value of 1). All luciferase reporter results
are an average of a minimum of three independent experiments.

Phalloidin staining
HIF-1α-3XSDM expressing clones H2, H4 and H6 and GFP-expressing clone G
were seeded on 60mm plates at a density of 1x105 cells/plate. Clones were differentiated
under 21 % oxygen for 7 days. Differentiated cells were fixed in 3.7 % paraformaldehyde
and stained with Rhodamine-conjugated phalloidin followed by staining with Hoechst
dye. Using FluorSave mounting media, glass cover slips were mounted on the plate
surface, and staining was observed by epifluorescence microscopy using a Nikon Eclipse
TE2000-5 phase contrast microscope.

Color overlay images were created using

Metamorph software. Images shown were captured at 40X magnification.

Gene cloning:
Plv-[CA-HIF-1α]-V5 cloning: pc3-HIF-1α-3XSDM construct was obtained from
Dr. Christina Warnecke (110).

The HIF-1α-3XSDM gene bears three site-directed

mutations which results in a protein that contains three amino acid substitutions that
eliminate key regulatory hydroxylation sites, inhibiting the protein’s turnover in ambient
oxygen and rendering it constitutively active in ambient oxygen. The HIF-1α-3XSDM
gene was excised from the plasmid using BamHI and ApaI restriction enzymes. The
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GFP gene was excised from the pLv-[GFP]-V5 construct, provided by provided by Dr. S.
Berberich, Wright State University, using BamHI and ApaI restriction enzymes.
Restriction products were resolved on 0.8% agarose gel and visualized by ethidium
bromide staining. The appropriate bands were excised and DNA was extracted from gel
using Qiagen gel extraction kit. The excised HIF-1α-3XSDM gene was ligated into pLv[GFP]-V5 plasmid using BamHI and ApaI compatible ends, using T4 DNA ligase
following the standardized cloning technique. Ligation was carried out overnight at 16oC
water-bath. Ligated constructs were transformed into competent DH5-alpha cells TM
(Invitrogen) and selected for ampicillin (50 μg/ml) resistance. DNA was isolated from
resistant cells and the construct was confirmed by differential digestion and sequencing
(Cleveland Genomics).

Lentiviral production:
293FT cell were transfected with pLv-[CA-HIF-1α]-V5 or pLv-[GFP]-V5 and
optimized Virapower TM packaging mix using Metafectene transfection reagent
(Biontex) as described earlier (65). Media (6 ml fresh media) was changed at 24 hrs post
transfection and virus was collected at 48-65 hrs after media change. Virus containing
media was centrifuged for 20 mins at 3,500 rpm. The supernatant was used for infection.
Unused supernatant was stored at –80oC (2 ml aliquots).
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Lentiviral concentration:
For infection of blastocysts, lentivirus was concentrated 100-200 fold. Viral
supernatant (4 ml) was mixed with 5X PEG-it virus precipitation solution (System
Biosciences) and incubated overnight at 4oC. The mix was then centrifuged at 3,000 rpm
for 30 minutes at room temperature. Supernatant was discarded and buff colored pellet
obtained was resuspended in 20 μl of 1XPBS containing 10 μg/ml polybrene. The
resuspended pellet was used for infections of blastocysts.

Blastocyst isolation and Culture:
Uteri were obtained from superovulated C57/Bl6 mice at 2.5 d.p.c. purchased
from Taconic farms. Uteri were cut between the ovary and the cervix. A blunted end 30gauge needle was inserted in the uterine cavity and withdrawn. The uteri were flushed
with M2 embryo culture media (50-100 μl). Isolated embryos were placed in Microdrop
culture, and incubated at 37 oC until further use (119).
Microdrop cultures were setup 6-24 hrs before use to allow for equilibration. In a
35 mm plate, 2-3 drops (40 μl each) of KSOM + 1/2 Amino acid media were placed
equidistant from each other. Embryo culture grade mineral oil was added to the plate
dropwise until oil covers drops and forms a thin layer over the drops. The plate was
incubated plate at 37 oC for 6-24 hrs before use. KSOM media was used within two
weeks of purchase.
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Blastocysts infection:
Concentrated virus was resuspended in 1XPBS and Polybrene was added to a
final concentration of 10 μg/ml. The solution was placed in a 35 mm plate, covered with
mineral oil (virus microdrop culture) and allowed to incubate for 30 minutes at 37oC prior
to treatment of blastocysts. Blastocysts at day 3.5 p.c. were treated with acidic Tyrode’s
solution for 30 seconds, for removal of the zona pellucida.

Blastocysts were

subsequently washed twice in M2 medium, and transferred into virus microdrop cultures
and incubated for 6hrs at 37oC. Post infection, blastocysts were transferred into KSOM
microdrop cultures at 37oC and were used for embryo transfer (120).

Embryo transfer:
Pseudopregnant Swiss Webster (SW) or ICR mice were purchased from Taconic
farms. Post Lentiviral infection, blastocysts were washed in M2 medium and six-eight
blastocysts were transferred into one uterine horn of a day 2.5 p.c. pseudopregnant
mouse.

Embryo and placenta isolation and fixation:
Pregnant mice were euthanized by CO2 asphyxiation. Embryos and placentas
were dissected in PBS. Tissues were placed in 4 % PFA in PBS and were fixed at 4oC
with rocking for 90-120 min. Paraformaldehyde treatment was followed by three quick
PBS washes. This was followed by 3 washes, 30 minutes each in cold PBS at 4oC with
rocking. After washes, the tissues were transferred into cold 30% sucrose in PBS at 4oC,
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overnight with rocking. The following day tissues were transferred into Tissue Tek
optimum cutting temperature (OCT) media (Electron microscopy sciences), and
embedded in OCT, wrapped in foil and stored at -80oC.

Embryo and placental section analysis:
For tissue section analysis embryos and placenta were sectioned using a Cryostat
to obtain 6 μm sections for placental analysis and 8-10 μm sections for embryo analysis.
Sections were collected on gelatin coated slides to increase adherence. Sections were
further

stained

using

hematoxylin

and

eosin

staining

or

were

used

for

immunocytochemistry analysis. Unused sections were stored at -20oC.

Hematoxylin and Eosin staining:
Tissue sections were dehydrated in 95 % ethanol followed by washes with tap and
then distilled water. Dehydrated sections were stained with Hematoxylin solution, Gill
No. 1 for 30 seconds. Sections were destained with 95 % ethanol treatment and counter
stained with Eosin Y alcoholic solution for 3 mins and 30 seconds. Destaining was
performed by treatment with 95 % ethanol followed by a 100 % ethanol treatment. Slides
were cleared with Xylene treatment. Coverslips were mounted with permount and sealed
with nailpolish. Stained slides were stored at room temperature. Hematoxylin and Eosin
stained sections were analyzed by bright field microscopy.
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Immunocytochemistry:
Placenta and embryo sections were hydrated with 3 washes in 1XPBS for 5
minutes each. Hydration was followed by permeabilization treatment with TritonX-100
(0.2 % TX-100 in PBS). Permeabilization was followed by quenching with glycine (1 %
in PBS). Sodium borohydrate (NaBH4 0.1 % in PBS) treatment for was used to quench
autoflourescence. The tissues were then blocked in blocking solution (Goat serum 10 %,
tween 0.05 % in PBS) for 1hr at room temperature. Primary antibodies were applied
overnight in 1 % blocking solution (V5-topo at 1:500) at 4oC overnight in a humidified
chamber.

The following day sections were washed with PBS and secondary antibody

(AlexaFlour 594, Goat anti rabbit at 1: 1000) was applied in 1 % blocking solution for
1hr at room temperature in a dark box. Sections were washed with PBS and treated with
Hoeschst stain (1 μg/ml) for 5 minutes at room temperature followed by 3 washes with
PBS. Using FluorSave mounting media, glass cover slips were mounted on the plate
surface, and staining was observed by fluorescence microscopy.

Tissue preparation and in situ hybridization
Conceptuses for in situ hybridization were dissected at E12.5, fixed overnight in 4
% paraformaldehyde (PFA) in PBS at 4°C, embedded in OCT and sectioned (9 μm).
Sections were placed on super frost slides as previously earlier. Digoxigenin-labeled
riboprobes were prepared according to the manufacturers protocol (Roche). Riboprobes
for Gcm1, Tpbpa, Prl3b1 and Pecam were used for staining labyrinthine,
spongiotrophoblast, trophoblast giant cells and endothelial cells respectively (25,26). In

44

situ hybridizations were performed by Dr. David Natale, Department of Veterinary
Medicine, University of Calgary, Calgary, Alberta, Canada.
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Results

Early embryonic development takes place under low oxygen conditions. The
trophoblast cells are the first to encounter changes in oxygen conditions during
implantation. An increase in oxygen is believed to act as a trigger for the initiation of the
differentiation process in trophoblasts. We analyzed the effect of low oxygen (3 %) on
the differentiation of trophoblast cells.

Effects of low oxygen on trophoblast cell differentiation:
Trophoblast stem cells (TS3.5), trophoblast giant cell lineage-specific Rcho-1
cells and labyrinthine lineage-specific SM-10 cells were maintained under differentiating
conditions under 3% and 21% oxygen, and induction of differentiation was examined by
analyzing expression of the inhibitor of differentiation 2 (Id2). High expression of Id2 is
observed in cells maintained in an undifferentiated/stem state, while decrease in levels of
Id2 are associated with the induction of differentiation (13). Analysis of Id2 expression
in TS3.5 cells maintained under 21 % oxygen revealed high levels of Id2 in
undifferentiated cells (U), while substantial decreases in the levels of Id2 were observed
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Figure 7: Low oxygen inhibits downregulation of the trophoblast stem marker,
inhibitor of differentiation 2 (Id2), in Trophoblast stem cells (TS3.5), labyrinthine
SM-10 cells and trophoblast giant Rcho-1 cells.
RT-PCR analysis of Trophoblast stem (TS3.5), Rcho-1 and SM10 cells maintained under
undifferentiated or differentiating conditions in low oxygen (3%) or ambient oxygen
(21%) using primers specific for Id2 is shown. Beta-actin was used as internal control.
U= undifferentiated, D= differentiated, Dc= differentiating conditions and M = 100bp
DNA molecular weight marker.
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under differentiating conditions (Dc) (Fig. 7). Under 3% oxygen, high expression of Id2
was observed in cells maintained under undifferentiated (U) as well as differentiating
conditions (Dc). Trophoblast giant cell, lineage-specific, Rcho-1 cells and labyrinthine
lineage-specific SM-10 cells exhibit results similar to TS cells. Little or no change in Id2
levels were observed in both cell lines maintained in 3% oxygen. High Id2 expression
was observed in Rcho-1 and SM-10 cells maintained in an undifferentiated state in 21%
oxygen while significantly decreased levels of Id2 were observed in both cell lines
maintained under differentiating conditions in 21% oxygen.

These results suggest that

low oxygen inhibits differentiation of trophoblast cells.

Expression of Hypoxia inducible factor-1 in trophoblast cells:
In mammals, hypoxia inducible factors (HIFs) family of transcription factors is
responsible for the regulation of gene expression under low oxygen. HIF-1α is the
predominant member of the HIF family. To determine the levels of HIF-1 in trophoblast
cells, nuclear extracts obtained from TS3.5, Rcho-1 and SM-10 cells maintained under
differentiating conditions in 3% and 21% oxygen were analyzed for HIF-1α protein
expression. HIF-1α protein was detected in all three cells lines in 3% oxygen; whereas
little to no HIF-1α protein was observed in 21% oxygen (Fig. 8). Nuclear extracts
obtained from Rcho-1 cells treated with Cobalt chloride (CoCl2) a hypoxia mimetic, were
used as a positive control.

HIF activity is regulated through several post- translational

modifications such as phosphorylation, and acetylation. To determine if the HIF-1α
protein observed in 3% oxygen was transcriptionally active, a luciferase reporter assay
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Figure 8:

Low oxygen stabilizes hypoxia inducible factor-1 alpha (HIF-1α) in

Trophoblast stem cells (TS3.5), labyrinthine SM-10 cells and trophoblast giant
Rcho-1 cells.
Western blot analysis of nuclear extracts isolated from Trophoblast stem (TS3.5), Rcho-1
and SM-10 cells maintained under differentiating conditions in low oxygen (3%) or
ambient oxygen (21%) as indicated, using polyclonal antibodies specific for HIF-1α is
shown. Antibodies specific for actin were used as loading control. Nuclear extracts
isolated from Rcho-1 cells treated with cobalt chloride (CoCl2) were used as a positive
control.
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Figure 9: Low oxygen induces HIF-1α activity in Trophoblast stem cells (TS3.5),
labyrinthine SM-10 cells and trophoblast giant Rcho-1 cells.
Hypoxia responsive element (HRE)-Luciferase reporter activation analysis of
Trophoblast stem (TS3.5), Rcho-1 and SM-10 cells maintained under differentiating
conditions in low oxygen (3%) or ambient oxygen (21%) is shown, using the
Phosphoglycerate kinase-1- (PGK-1)-HRE-luciferase reporter plasmid.

Cells were

transfected with the pGL3-6X-PGK1-HRE-luciferase reporter plasmid and maintained
under differentiating conditions in the indicated oxygen levels. Reporter activity in low
oxygen is shown relative to reporter activation in ambient oxygen, which was set to 1
(mean ± S.D., n = 3). Significance (*, p ≤ 0.05) was determined using Student’s t test.
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was performed using the phosphoglycerate kinase-1-hypoxia response element reporter
construct (PGK-1-HRE). TS3.5, Rcho-1 and SM-10 cells were transfected with PGK-1HRE and were induced to differentiate in 3% or 21% oxygen and induced to differentiate.
For each cell line, fold change in luciferase activity is shown relative to luciferase activity
in 21% oxygen. TS cells maintained under differentiating conditions show a 14.3 fold
increase in luciferase activity in 3% oxygen when compared with cells maintained in
21% oxygen (Fig. 9). A 8.1 fold increase in luciferase activity was observed in Rcho-1
cells maintained in 3% oxygen when compared with cells maintained in 21% oxygen,
while SM-10 cells show a 4.4 fold increase in luciferase activity was observed in cells
maintained in 3% oxygen when compared with cells maintained in 21% oxygen.
Together these results suggest that the HIF-1α protein observed in TS3.5, Rcho-1 and
SM-10 cells under 3% oxygen is active. High levels of HIF-1α protein is observed in
TS3.5, Rcho-1 and SM-10 cells that fail to differentiate, when induced, in 3% oxygen,
whereas little to no protein or activity is observed in cells that differentiate under 21%
oxygen. These results suggest that trophoblast cells maintained under differentiating
conditions in 3% oxygen, fail to differentiate, and exhibit high levels of transcriptionally
active HIF-1α.

Generation of Rcho-1 clones expressing constitutively active form of HIF-1α:
As observed earlier, a decrease or loss of HIF-1α protein correlated with the
induction of differentiation of trophoblast cells. We hypothesized that HIF-1α may be a
potential mediator of low oxygen’s inhibition of trophoblast cell differentiation. To test
this hypothesis, Rcho-1 cells were chosen. The Rcho-1 cells belong to the trophoblast
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giant cell lineage. The trophoblast giant cells (TGCs) form the outer most layer of the
placenta, and invade the maternal decidua to implant the embryo. The TGCs are also the
first to encounter an increasing gradient of oxygen as they differentiate and invade the
maternal arteries during implantation.

The Rcho-1 cells are undifferentiated, TGC-

lineage committed cells and represent an ideal population to study the effect of prolonged
HIF-1α expression on differentiation. Undifferentiated Rcho-1 cells were transfected
with a plasmid encoding either a green fluorescent protein -pEGFP-N1 or a plasmid
encoding an oxygen-insensitive form of HIF-1α- pC3-HIF-1α-3xSDM.

Three site-

directed mutations within the oxygen dependent degradation domain (ODD) eliminate
key regulatory hydroxylation sites, thus inhibiting protein degradation in ambient oxygen
and rendering it constitutively active in ambient oxygen.

Clonal populations were

isolated from stable pools as previously mentioned in the materials and methods. From a
set of multiple clones, three clones were selected exhibiting low, medium and high HIF1α expression. GFP-expressing clone (G) was confirmed by fluorescent microscopy
(Fig. 10). No alterations in morphological characteristics were observed due to increased
expression of HIF-1α in HIF-1α clones H2, H4 and H6, when compared with the GFPexpressing clone G. The HIF-1α clones were confirmed by analyzing for the genomic
integration of the pC3-HIF-1α-3xSDM plasmid (Fig. 11A). Genomic PCR analysis was
performed using a 5’ primer specific for a sequence present within the CMV region of
pC3-HIF-1α-3xSDM plasmid, while 3’ primer was specific for a unique Hif-1α
sequence. pC3-HIF-1α-3xSDM plasmid was used as a positive control, exhibiting a
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Figure 10: Confirmation of pEGFP-N1 clones.
Rcho-1 cells stably expressing pEGFP-N1 (G) or HIF-1α-3SXDM (H2 H4 and H6) were
analyzed for GFP expression using fluorescence microscopy (upper panels).
Corresponding bright field photos (lower panels) are shown as controls. 40X
magnification, scale bar = 100 μm.
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band at the same molecular weight. Genomic DNA isolated from untransfected Rcho-1
cells was used as a negative control.
Expression of HIF-1α in the clones was examined by Western blot analysis.
Nuclear extracts from HIF-1α clones H2, H4 and H6 and GFP clone G were analyzed for
HIF-1α expression using a polyclonal antibody that recognizes both the endogenous and
the constitutively-active form of the protein (Fig. 11B). Little to no HIF-1α protein was
observed in GFP-clone G, HIF-1 clone H2 expressed low protein levels. Clone H4
expressed higher levels of HIF-1, while clone H6 expressed the highest amount of HIF1α protein in ambient oxygen. To test whether the observed HIF-1α protein was active,
HIF-1 transcriptional activity in HIF-1α-3xSDM clones was analyzed by luciferase
reporter assays performed in ambient oxygen (Fig. 11). HIF-1α clones were transfected
with the PGK1-HRE-luciferase reporter, and maintained under ambient oxygen
conditions. Reporter activity was analyzed in clones G, H2, H4 and H6. For each HIF1α clone, fold change in luciferase activity is shown relative to luciferase activity in GFP
clone G. For ease of interpretation, reporter activity in clone G was set to 1. HIF-1α
clones stably expressing the constitutively active form of HIF-1α (H2, H4, and H6),
upregulated the activity of the PGK1-HRE luciferase reporter by 2-3 fold over activity in
GFP-expressing clones. Clone H2 showed a 1.75 fold increase, clone H4 exhibited a
2.25 fold increase, while clone H6 upregulated reporter activity by 3 fold. This result
demonstrates that although clone H2 exhibits levels of HIF-1α protein similar to GFP
clone G, the H2 clone is expressing the stable, active form of the HIF-1α protein which
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Figure 11: Confirmation of HIF-1α-3XSDM clones.
(A) Genomic PCR analysis of Rcho-1 cells stably expressing either pEGFP-N1 (G) or
HIF-1α3xSDM (H2, H4, H6). Genomic PCR was performed using CMV promoter
forward primer and Hif-1α reverse primer. Beta-actin was used as an internal control.
P1=plasmid encoding HIF-1α and R=Rcho-1 genomic DNA. M= 100bp DNA molecular
weight marker.

(B) Western blot analysis of HIF-1α protein levels in clones stably

expressing pEGFP-N1 (G) or HIF-1α-3xSDM (H2, H4, H6). Nuclear extracts isolated
from clones maintained in the undifferentiated under ambient oxygen were probed using
polyclonal antibodies specific to HIF-1α. Actin protein levels were also analyzed to
confirm equal loading. Rcho-1 cells treated with cobalt chloride (CoCl2) and Cos7 cells
expressing the HIF-1α-3xSDM plasmid (Cos7) were used as positive controls. (C)
Hypoxic Response Element (HRE) luciferase reporter activity in Rcho-1 cells stably
expressing either pEGFP-N1 (G) or HIF-1α-3xSDM (H2, H4, H6).

Clones were

transfected with the pGL3-6X-PGK1-HRE-luciferase reporter plasmid and a pRLSV40
control reporter to control for transfection efficiency. Cells were cultured in ambient
oxygen. Luciferase activity in HIF-1α-3XSDM clones is shown relative to activity in
GFP clones, which was set at 1 (mean ± S.D., n = 3).
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exhibits higher transcriptional activity in ambient oxygen when compared with the
endogenous HIF-1α protein observed in the GFP-clones. This result demonstrates that
the oxygen-insensitive, HIF-1α-3xSDM protein is expressed and active in the HIF-1αexpressing Rcho-1 clones H2, H4, and H6.

Lineage analysis of HIF-1α expressing clones:
Previous reports suggest that loss of HIF-1α in trophoblast cells alters their
lineage commitment (58,121). To test if increased HIF-1α expression alters lineage
commitment, HIF-1α clones H2, H4, and H6 were analyzed for the expression of Hand1, Tpbpa/4311 and Tec by RT-PCR analysis (Fig. 12). Hand-1 is a TGC lineage –
specific marker. Clones H2, H4 and H6 exhibit high levels of Hand-1 under both
undifferentiated and differentiating conditions (Fig. 12A). Untransfected Rcho-1 cells
were used as a positive control. Beta-actin was used as an internal control. Tpbpa/4311
is a spongiotrophoblast lineage-specific marker (Fig. 12B). HIF-1α and GFP clones
maintained in undifferentiated (U) and differentiating conditions (Dc) were analyzed for
Tpbpa/4311 expression. Clones H2, H4 and H6 do not exhibit Tpbpa/4311 expression
under both undifferentiated and differentiating conditions.

Upon differentiation,

trophoblast stem cells express markers from all the three trophoblast lineages.
Differentiated trophoblast stem cells exhibit Tpbpa/4311 expression and were used as a
positive control. Beta-actin was used as an internal control to ensure equal loading. Tec
is a labyrinthine lineage-specific marker. HIF-1α clones maintained in undifferentiated
(U) and differentiating conditions (Dc) were analyzed for Tec expression (Fig 12C).
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Figure 12: Prolonged expression of HIF-1α protein does not affect lineage
commitment of Rcho-1 trophoblast giant cells.
RT-PCR analysis of lineage specific markers was performed on pEGFP-N1 expressing
Rcho-1 clone G and HIF-1α3XSDM expressing clones H2, H4 and H6 maintained under
differentiating conditions in ambient oxygen (21%) using primers specific for (A)
trophoblast giant cell specific Hand-1, (B) Labyrinthine cell specific Tec and (C)
Spongiotrophoblast specific Tpbpa/4311 is shown. Primers specific for beta-actin were
used as internal control. R= Rcho1 cells, S= SM-10 cells, Ts= differentiated trophoblast
stem cells, U= undifferentiated, DC= differentiating conditions and M = 100 bp DNA
molecular weight marker.
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Figure 13: Prolonged HIF-1α expression inhibits molecular differentiation of Rcho1 trophoblast giant cells.
RT-PCR analysis of Rcho-1 clones stably expressing either GFP (G) or HIF-1α-3XSDM
(H2, H4, and H6) cultured in ambient oxygen (21%) for 7 days under undifferentiated or
differentiating conditions was performed using primers specific for stem cell marker Id2
(497 bp). Beta-actin (243 bp) was used as internal controls. U= undifferentiated, Dc=
differentiating conditions and M = 100 bp DNA molecular weight marker.
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Clones H2, H4 and H6 do not exhibit Tec expression under both undifferentiated and
differentiating conditions.

Labyrinthine lineage-committed SM-10 cells exhibit Tec

expression and were used as a positive control. Beta-actin was used as an internal control
to ensure equal loading.

Together these results suggest that overexpression of

constitutively active HIF-1α does not alter the lineage commitment of TGC.

Analysis of Id2 expression in HIF-1α expressing clones:
To determine if constitutively active HIF-1α expression altered the differentiation
of Rcho-1 cells to the trophoblast giant cell phenotype, as is observed in low oxygen
conditions, HIF-1α-expressing clones H2, H4, and H6 were maintained under
differentiating conditions in ambient oxygen (21% oxygen) for 7 days. Differentiation
was also simultaneously induced in GFP-expressing Rcho-1 clones as controls (Fig. 13).
Induction of differentiation was analyzed by determination of Id2 expression in the cells.
RT-PCR analysis demonstrated that GFP-expressing cells down-regulated the expression
of Id2 upon differentiation when compared to undifferentiated cells. HIF-1α-3xSDM
clones H2, H4, and H6 cultured under differentiating conditions, continued to express
detectable levels of Id2 mRNA, a marker of trophoblast stem cells, suggesting an
inhibition of the differentiation process in the presence of active HIF-1α. This data
suggest that increased expression of HIF-1α inhibits TGC differentiation at the molecular
level.
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Analysis of chorionic somatomammotropin hormone-1 (CSH1) protein expression
in HIF-1α- expressing clones:
The functional, terminal differentiation of trophoblast giant cells is also marked by the
production of chorionic somatomammotropin hormone-1 (CSH1) protein (112,122).
CSH1 is a hormone secreted by differentiated TGCs. Western blot analysis of the
cytoplasmic proteins isolated from clones reveals only differentiated GFP-expressing
clones produced detectable levels of CSH1 protein (Fig. 14). HIF-1α clones H2, H4, and
H6 cultured under differentiating conditions in ambient oxygen produce little to no CSH1
protein.

These data suggest that increased expression of HIF-1α inhibits TGC

differentiation at the functional level.

Analysis of palladin protein expression in HIF-1α- expressing clones:
Upregulation of palladin a cytoskeleton-associated protein occurs during
differentiation of TGCs. Western blot analysis was performed to determine levels of
palladin protein present in clones upon induction of differentiation. The control GFPexpressing clones also showed the high expression of palladin protein levels upon
induction of differentiation (Fig. 15). In contrast, HIF-1α-expressing cells exhibited
variable but consistently lower levels of palladin protein when compared to GFPexpressing controls. This result demonstrates that increased expression of the active form
of HIF-1α inhibits cytoskeletal changes associated with the differentiation of TGCs.
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Figure 14: Prolonged HIF-1α expression inhibits functional differentiation of Rcho1 trophoblast giant cells.
Rcho-1 clones expressing GFP, G or HIF-1α-3XSDM clones H2, H4, and H6 were
cultured in ambient oxygen for 7 days under differentiating conditions. Cytoplasmic
extracts were analyzed for CSH1 protein levels by Western blot analysis using CSH1specific polyclonal antibodies. A non-specific cross- reactive band, insensitive to oxygen
levels, was used as a loading control.
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Analysis of Cytoskeletal stress fiber formation in HIF-1α expressing clones:
TGCs exhibit a significant increase in cell size upon differentiation. The increase
in cell size is accompanied by the appearance of cytoskeletal stress fibers. Cytoskeletal
stress fiber formation was detected by phalloidin staining.

GFP-expressing cells

differentiated in ambient oxygen exhibited differentiation-induced stress fiber formation
(Fig.16). HIF-1α–expressing clone H2 showed increase in cell size, with little to no
stress fiber formation, H4 showed little change in morphology with the absence of stress
fiber formation. Clone H6 showed no change in cell morphology, with an absence of
stress fiber formation (Fig 16, H2, H4, H6).

Together these results suggest that

expression of the constitutively active form of HIF-1α inhibits differentiation of
trophoblast giant cells, and the inhibition of differentiation corresponds with the level of
HIF-1α protein expressed. Results indicate, in cell culture conditions, the constitutively
active form of HIF-1α is sufficient to mimic the effect of low oxygen, by inhibition of
trophoblast giant cell differentiation.
To determine the effect of HIF-1α-induced inhibition of trophoblast
differentiation on placental development, we analyzed the effect of prolonged HIF-1α
expression on placental and embryonic development in vivo.
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Figure 15: Prolonged HIF-1α expression inhibits morphological differentiation of
Rcho-1 trophoblast giant cells.
Rcho-1 clones expressing GFP, G or HIF-1α-3XSDM clones H2, H4, and H6 were
cultured in ambient oxygen for 7 days under differentiating conditions. Equal volumes of
cell lysates collected in boiling Laemmli buffer were analyzed for palladin protein levels
by Western blot analysis. Equal loading was confirmed by Ponceau S staining.
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Figure 16: Prolonged HIF-1α expression inhibits morphological differentiation of
Rcho-1 trophoblast giant cells.
Rcho-1 clones expressing GFP, G or HIF-1α-3XSDM clones H2, H4, and H6 were
cultured in ambient oxygen for 7 days under differentiating conditions. Stress fiber
formation was analyzed using Rhodamine-conjugated Phalloidin stain (red). Nuclei were
stained using Hoechst dye (blue). Stained cells were analyzed for stress fiber formation
using fluorescence microscopy at 40X magnification. Scale bar = 100 μm. Stress fibers
are indicated by white arrows.
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Blastocysts isolation culture and embryo transfer:
To establish embryo culture and transfer conditions, fertilized eggs were isolated
from 3-4 week old superovulated C57B/6 (black) mice at day 2.5 p.c. The fertilized eggs
on day 2.5 represent the morula stage.

Isolated morulas were placed in a KSOM

microdrop culture overnight, to progress to the blastocyst stage (day 3.5 p.c.) (Fig. 17A).
Mature blastocysts were selected and uterine embryo transfers were performed (Fig.
17B). Embryos were transferred into 6-8 week old pseudopregnant ICR (white) females
on day 2.5 p.c. Pregnancy was carried out to term. Black pups were born on day 17 post
embryo transfers (Fig. 18). Result suggests successful establishment of embryo culture
and embryo transfer technology.

Lentiviral transduction of Blastocysts:
Previous reports have demonstrated placental-specific lentiviral transduction of
genes through the infection of day 3.5 blastocysts (120,123). We first established the
system by targeting GFP expression to the placenta. We transduced day 3.5 blastocysts
with a GFP-expressing lentivirus, pLV-[GFP]-V5 (Fig. 19A). Fertilized embryos were
isolated at day 2.5 post-coitum (p.c.) from superovulated C57BL/6 mice. Embryos were
then transferred into KSOM microdrop cultures overnight at 37oC. The following day,
embryos in the blastocyst stage were selected, the zona pellucida was removed, and
blastocysts were infected with 100X pLV-[GFP]-V5 virus. Post-infection, blastocysts
were washed in M2 followed by KSOM and transferred into KSOM microdrop cultures.
GFP expression was analyzed by fluorescence microscopy.
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Trophoblast-specific

expression of GFP was observed in the infected blastocysts, with expression specific to
the outermost layer of the blastocyst (Fig. 19B).

Analysis of V5 epitope tag expression in pLV-[GFP]-V5-infected placenta:
To ascertain the specificity of lentiviral infections, blastocysts at 3.5 d.p.c. were
infected with lentivirus carrying pLV-[GFP]-V5 construct and transferred into
pseudopregnant ICR mice. Fetoplacental units were obtained on embryonic day 10.5
(E10.5). Tissues were fixed in paraformaldehyde. Eight μm sections were analyzed for
GFP expression using fluorescence microscopy. GFP expression was observed restricted
to the placental layer (P), while both the maternal decidua (D) and embryo (E) did not
exhibit GFP expression (Fig. 20).

Expression of lentivirally-transduced GFP was

confirmed by immunocytochemical staining of the placental sections for V5 epitope tag.
The V5 epitope is present in frame at the end of the EGFP reading frame followed by
stop codon. GFP placental-specific expression was observed by epifluorescence
microscopy (Fig 21A).

GFP expression was observed throughout the placenta. V5

epitope expression was performed by probing sections with polyclonal antibodies specific
to the V5 tag.

V5 tag (red) expression was observed throughout the placenta by

immunocytochemical analysis (Fig 21B). Colocalization of the GFP expression and V5
staining was observed in pLV-[GFP]-V5 –infected placenta (yellow) (Fig 21C). Hoechst
staining was performed for the visualization of nuclei (Fig 21D). These results suggest
that the lentivirus was successful in transducing the blastocysts. Transduction of the
blastocysts on day 3.5 p.c. exhibited a trophoblast-specific infection, which resulted in
placental specific expression of the transgene.
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Figure 17: Establishment of embryo microdrop cultures.
Embryos were isolated from the uteri of superovulated C57/B6 (black) females on day
2.5 p.c. Embryos were transferred to KSOM microdrop cultures (A) equilibrated
overnight at 5% CO2. Isolated embryos were cultured overnight to progress to the
blastocyst stage (B); mature blastocysts were further selected for embryo transfers.
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Figure 18: Uterine embryo transfer.
Embryos were isolated from the uteri of 3-4 week old superovulated C57/B6 (black)
females on day 2.5 p.c.

Embryos were transferred to KSOM microdrop cultures

equilibrated overnight at 5% CO2.

The next day 6-8 blastocysts at day 3.5 were

transferred into pseudopregnant ICR (White) mice at day 2.5 p.c. via uterine transfer, and
pregnancy was carried to full term (17-19 days post embryo transfer) to obtain pups.
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Figure 19: Trophoblast specific GFP expression is observed in blastocysts infected
with pLv-[GFP]-V5 virus.
Day 3.5 p.c. mouse blastocysts devoid of the zona pellucida layer were infected with
100X concentrated lentivirus carrying GFP gene (pLv-[GFP]-V5) and 10 μg/ml
Polybrene for 6 hrs at 37oC. Post-infection GFP expression was examined in infected
blastocysts using fluorescence microscopy.
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Figure 20: Blastocysts infected with pLv-[GFP]-V5 virus exhibit placental-specific
GFP expression.
Day 3.5 p.c. mouse blastocysts devoid of the zona pellucida layer were infected with
100X concentrated lentivirus carrying GFP gene (pLv-[GFP]-V5) and 10 μg/ml
Polybrene for 6 hrs at 37oC.

Post-infection, 6-8 blastocysts were transferred into

pseudopregnant ICR mice via uterine transfer. Fetal-placental units (FPU) were obtained
on embryonic day 10.5 (E10.5). FPU’s were fixed in paraformaldehyde and embedded in
O.C.T. media. Six-eight micron sections were examined for GFP expression.
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Figure 21: Placentas exhibiting GFP expression, exhibit positive staining for V5
epitope tag.
Day 3.5 p.c. mouse blastocysts devoid of the zona pellucida layer were infected with
100X concentrated lentivirus carrying GFP gene (pLv-[GFP]-V5) and 10 μg/ml
Polybrene for 6 hrs at 37oC.

Post-infection, 6-8 blastocysts were transferred into

pseudopregnant ICR mice via uterine transfer. Placentas were obtained on embryonic
day 12.5 (E12.5). Tissues were fixed in paraformaldehyde and embedded in O.C.T.
media. Six-eight micron sections were examined for V5 epitope tag expression by
immunocytochemistry analysis. Polyclonal antibodies specific to V5 epitope were used
(red), nuclei were observed using Hoechst staining (blue). A= GFP expression, B = V5
epitope staining, C= GFP expression and V5 staining overlay and D= GFP expression
and V5 staining overlay with Hoechst staining.
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Generation of pLV-[CA- HIF-1α]-V5 construct:
Previous results suggest that expression of the oxygen insensitive form of HIF-1
in trophoblast giant cells inhibits differentiation of giant cells. Studies also suggest that
the loss of enzymes involved in the degradation of HIF cause embryonic lethality. We
generated a lentivirus-based plasmid encoding a constitutively active form of HIF-1α
protein (65,110). The HIF-1α gene was cloned in frame into pLV-[GFP]-V5, by
replacing the GFP gene to generate the pLV-[CA- HIF-1α]-V5 construct (Fig. 22C).
High levels of HIF-1α protein expression were observed under ambient oxygen
conditions when transiently transfected into Cos7 cells (Fig. 22A). The pLV-[CA- HIF1α]-V5 also showed significant activation of the Phosphoglycerate kinase-hypoxia
responsive element- luciferase reporter (PGK-HRE-luciferase) indicating the expressed
protein was transcriptionally active under ambient oxygen conditions and confirms
functionality HIF-1α (Fig 22B).
Increased expression of HIF-1 due to the loss of HIF degradation enzymes has
been suggested to play a role in the embryonic death observed in PHD2 and VHL KO
mice (89).

Similarly, increased expression of HIF-1 due to the loss of catechol-o

methyltransferase (comt) is believed to give rise to a preeclamptic phenotype in mice.
Since several studies suggest the involvement of HIF-1 in the pathogenesis of
preeclampsia, which is believed to arise due to insufficiencies in placenta formation, we
hypothesize that the deficiencies in placenta formation and functionality observed in the
preeclamptic phenotype occurs due to prolonged HIF-1 expression.
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Morphological analysis of pLV-[CA- HIF-1α]-V5-infected embryos and placenta:
Embryos and placentas from pLV-[CA-HIF-1α]-V5-infected blastocysts were
obtained on E12.5. Embryos obtained from pLV-[CA-HIF-1α]-V5-infected blastocysts
appeared morphologically normal compared with E12.5 pLV-[GFP]-V5-infected
embryos (Fig. 23). Placentas obtained from pLV-[CA-HIF-1α]-V5-infected blastocysts
exhibited hemorrhaging on the maternal side and were smaller in size and weight when
compared with the placentas obtained from pLV-[GFP]-V5-infected blastocysts (Fig. 23).

Expression of V5 epitope tag in embryo and placenta infected with of pLV[CA- HIF-1α]-V5 and pLv-[GFP]-V5:
To specifically identify the expression of constitutively expressed HIF-1α, V5
expression analysis using immunohistochemistry was performed. No V5 staining was
observed in the embryo, confirming no leakage of the pLv-[CA-HIF-1α]-V5 lentivirus
into the ICM/ embryo placental specific CA-HIF-1α expression (Fig. 24). V5 expression
was observed throughout the placenta infected with pLv-[CA-HIF-1α]-V5 lentivirus
(red) (Fig. 25).

Histological analysis of placental sections:
Since expression of the CA-HIF-1α was specific to the placenta, we analyzed the
placentas obtained from pLv-[CA-HIF-1α]-V5-infected blastocysts for possible
alterations in the morphology. Histological analysis of placental sections obtained from
pLv-[CA-HIF-1α]-V5-infected blastocysts exhibited a significant decrease in the size of
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Figure 22: HIF-1α-3XSDM gene was cloned into Lentiviral vector.
HIF-1α-3XSDM gene was excised from pc3- HIF-1α-3XSDM plasmid and ligated into
pLv-[GFP]-V5 lentivirus plasmid using BamHI and ApaI restriction enzymes. Cos7 cells
were transiently transfected with pLv-[CA-HIF-1α]-V5 lentivirus or pc3-HIF-1α3XSDM and HIF-1α expression was analyzed under ambient oxygen conditions (A) by
Western blot analysis using polyclonal antibodies specific to HIF-1α and (B) PGK-1HRE reporter activity was determined using Luciferase reporter assay. Antibodies
recognizing actin were used a loading control.
confirmed by sequencing. pLb2V5 = empty vector.
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pLv-[CA-HIF-1α]-V5 cloning was
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Figure 23: Prolonged HIF-1α protein expression affects placental and embryonic
development in vivo.
Day 3.5 p.c. mouse blastocysts devoid of the zona pellucida layer were infected with
100X concentrated lentivirus carrying pLv-[CA- HIF-1α]-V5 and 10 μg/ml Polybrene for
6 hrs at 37oC. Post-infection, 6-8 blastocysts were transferred into pseudopregnant ICR
mice via uterine transfer. Placentas and embryos were obtained on embryonic day 12.5
(E12.5) for analysis. Arrows indicate hemorrhage.
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Figure 24: Immunocytochemical analysis of V5 epitope staining in embryos infected
with pLv-[CA- HIF-1α]-V5.
Embryos were obtained on embryonic day 12.5 (E12.5) from pLv-[CA- HIF-1α]-V5
infected embryos. Tissues were fixed in 4 % paraformaldehyde and embedded in O.C.T.
media. Embryonic sections (10 µM) were analyzed for HIF-1α expression by
immunocytochemistry using antibodies specific to V5 epitope tag as described in the
material and methods. V5 expression is shown in red and Hoechst staining (blue) was
used for detection of nuclei. Scale bar= 200μm.
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Figure 25: Immunocytochemical analysis of placentas infected with pLv-[CA- HIF1α]-V5 confirms the prolonged expression of the HIF-1α.
Placentas were obtained on embryonic day 12.5 (E12.5) from pLv-[CA- HIF-1α]-V5
infected embryos. Tissues were fixed in 4% paraformaldehyde and embedded in O.C.T.
media. Placental sections (8 µM) were analyzed for HIF-1α expression by
immunocytochemistry using antibodies specific to V5 epitope tag as described in the
material and methods. V5 expression is detected as red staining and Hoechst staining
(blue) was used for detection of nuclei. Scale bar= 200μm.
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the labyrinthine layer, when compared with placenta obtained from blastocysts infected
with pLv-[GFP]-V5 (Fig. 26). The arrows indicate hemorrhaging.

In situ hybridization analysis of pLv-[GFP]-V5 and pLv-[CA-HIF-1α]-V5infected placenta:
Increased HIF-1α expression has been previously shown to inhibit differentiation
of trophoblast giant cells (65). Severe placental defects have also been identified in mice
lacking PHD2 and VHL, both enzymes involved in HIF-1α degradation, allowing for
prolonged HIF expression (99,102).

Hence we analyzed for the expression of

endothelial, labyrinthine, spongiotrophoblast and trophoblast giant cell-specific markers
using in situ hybridization.

In situ analysis of the GFP and CA-HIF-1α-infected

placentas revealed significant defects in the placenta formation in CA-HIF-1α-infected
placenta. Endothelial cell distribution was analyzed using Pecam-1 staining (Fig 27).
Abundant Pecam-1 staining was observed in the labyrinth of pLv-[GFP]-V5-infected
placenta, but was significantly decreased. Decreased Pecam-1 staining was observed in
placenta infected with pLv-[CA- HIF-1α]-V5 suggesting decreased vascularization in
pLv-[CA- HIF-1α]-V5-infected placenta. Unexpectedly, Pecam-1 staining was observed
in cells lining the maternal spiral arteries of the pLv-[CA- HIF-1α]-V5 infected mice at a
time when no pecam-1 staining should be present (Fig 27, red inset). Gcm-1 staining was
performed for the analysis of labyrinthine layer, while abundant staining was observed in
the pLv-[GFP]-V5 placenta in a ‘string-like pattern’, significantly decreased staining was
observed in the pLv-[CA-HIF-1α]-V5 infected placenta. This result suggests decreased
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labyrinthine cell differentiation. Spongiotrophoblast analysis was performed by Tpbpa
staining.

While no significant difference was observed in the morphology of the

spongiotrophoblast layer between the pLv-[GFP]-V5 and pLv-[CA- HIF-1α]-V5 infected
placentas, a decrease in Tpbpa staining was observed in the labyrinthine layer of the pLv[CA-

HIF-1α]-V5-infected

placenta,

suggesting

decreased

spongiotrophoblast

differentiation (Fig. 27). Prl3b1 (Pl2) staining was performed to analyze the distribution
of trophoblast giant cells. Prl3b1 (Pl2) is a trophoblast giant cell marker that marks a
subpopulation of giant cells which occur within the labyrinthine and spongiotrophoblast
cell layer. Although, Prl3b1 staining was detected in spongiotrophoblast layer as well as
the labyrinthine layer in both pLv-[GFP]-V5 and pLv-[CA-HIF-1α]-V5-infected
placentas, decreased penetration of Prl3b1 positive cells was observed in the labyrinthine
layer, data suggests decreased giant cells differentiation.
These data suggest that HIF-1α plays a significant role during placental
development, and that deregulation of HIF-1α affects trophoblast differentiation and
placental development in vivo.
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Figure 26: Prolonged HIF-1α protein expression alters placental morphology.
Placentas were obtained on embryonic day 12.5 (E12.5) from pLv-[CA-HIF-1α]-V5
infected embryos. Tissues were fixed in 4 % paraformaldehyde and embedded in O.C.T.
media. Placental sections (8 µM) were analyzed by Hematoxylin and Eosin staining. A=
Represents pLv-[CA-HIF-1α]-V5-infected placentas and B= pLv-[GFP]-V5-infected
placentas. S= Spongiotrophoblast cell layer and L= Labyrinthine cell layer. Arrows
indicate hemorrhage.
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Figure 27: Prolonged HIF-1α protein expression affects differentiation and
distribution of labyrinthine cells, spongiotrophoblast cells, trophoblast giant cells
and endothelial cells in the placenta in vivo.
Placentas were obtained on embryonic day 12.5 (E12.5) from pLv-[CA-HIF-1α]-V5
infected embryos. Tissues were fixed in 4% paraformaldehyde and embedded in O.C.T.
media. Placental sections (8 µM) were analyzed for Labyrinthine marker Gcm-1,
spongiotrophoblast marker Tpbpa, trophoblast giant cell marker Prl3b1 and endothelial
cell marker Pecam1 expression by in situ hybridization analysis. A= Illustration
indicating the placental lineage-specific markers, B= In situ hybridization analysis of
placental lineage-specific markers. Positive staining is seen as blue –dark blue coloring
in the stained sections. Sections were stained with eosin (pink).
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Discussion

Effect of low oxygen on differentiation of trophoblast cells:
Early development takes place under low oxygen conditions.

The early

trophoblast cell layer is exposed to low oxygen during development, but as implantation
progresses, gradual increase in the levels of oxygen occur. We determined the effect of
prolonged exposure to low oxygen on the differentiation of Trophoblast stem (TS) cells.
TS cells maintained under differentiating conditions in low oxygen exhibit high levels of
Id2, a marker of the stem cell state, while little to no Id2 was observed in ambient oxygen
upon differentiation. The result suggests that the TS cells fail to differentiate under low
oxygen conditions. In vivo, low oxygen levels persist in the uterine cavity under which
the fertilized egg undergoes several rounds of cell division. Low oxygen has been shown
to induce proliferation in several cell types and HIF-1 is believed to orchestrate this
process. Upregulation of several genes involved in cell division, such as TERT, have
been observed in cells maintained under low oxygen (124). These observations are
consistent with the maintenance of a proliferative state in the TS cells.
TS cells downregulate Id2 expression in ambient oxygen (21%), which suggests
the loss of a proliferative phenotype and the adaptation to a more non-proliferative or
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differentiated state. This result is consistent with the in vivo phenomena of implantation
wherein gradual increases in levels of oxygen occurs, allowing for cells to adapt to a
differentiated phenotype capable of performing defined functions. To determine whether
the low oxygen-induced inhibition was restricted to stem cells or specific to certain
placental lineages, the trophoblast giant cell lineage-committed Rcho-1 and labyrinthine
cell lineage-committed SM-10 cells were induced to differentiate under low oxygen. The
Rcho-1 cell line was isolated from a rat choriocarcinoma and has been extensively used
as a model to study trophoblast giant cells. The SM-10 cells have been isolated from the
labyrinthine region of the mouse placenta and have previously been shown to exhibit
labyrinthine properties.

Although lineage-committed, both SM-10 and Rcho-1 still

exhibit a “stem-cell like” state and can be differentiated in culture to adapt to a
functionally differentiated state.

Previous studies have shown that both cells, upon

induction of differentiation alter several cell characteristics such alteration in
morphology, changes in glucose uptake, secretion of hormones, etc. (12,13,65). The two
cell lines represent two of the three lineages present in a functional rodent placenta;
currently there is no cell line available to represent the third, spongiotrophoblast lineage.
Similar to the TS cells, the SM-10 and Rcho-1 cell lines exhibit high levels of Id2 in low
oxygen suggesting an inhibition of differentiation in low oxygen conditions, while in
ambient oxygen conditions little to no Id2 is observed, suggesting induction of
differentiation. Increasing levels of oxygen have been shown to induce differentiation of
the trophoblast giant cells in a step-wise manner, with the adaptation of a fully functional
and differentiated state at an oxygen concentration of more than 10%, which is consistent
with the levels of oxygen observed in the maternal arteries (8-12%) (31-34). The SM-10
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cells represent the labyrinthine cell lineage, which lies closest to the baby. The labyrinth
mediates the gaseous and nutrient exchange between baby and the mother, and is heavily
vascularized. In vivo, the labyrinth is formed between embryonic days 9-10 (E 9-10) in
mice, while implantation occurs at E 5.5 (Reviewed in 125,126). Thus the labyrinthine
layer is the last to form and is developed after implantation, when the oxygen levels have
increased to maternal arterial levels. Consistent with this, our results suggest that 3%
oxygen inhibits differentiation of the SM-10 cells, while abundant oxygen exhibits a
reduction in the levels of Id2 during differentiation. Although the trophoblast cells in
vivo would never encounter 21% oxygen, previous studies have shown that trophoblast
cells exhibit similar differentiation patterns at 10% and 21% oxygen (65).

Expression and activity of HIF-1α in trophoblast cells maintained in low oxygen:
The hypoxia inducible factor family of transcription factors is believed to regulate
gene expression in low oxygen conditions. HIF-1 is believed to be the predominant
member of this family due to its presence in most all cell and tissue types. HIF-1α is
known to have an extremely short half-life in abundant oxygen (less than 5 min) and a
decrease in oxygen levels causes a significant increase in HIF-1α half-life

(43,127).

This rapid degradation of HIF-1α is attributed to the rapid activation of the HIF-1αdegradation machinery in elevated oxygen. Consistent with this regulation, TS cells
maintained under differentiating conditions in ambient oxygen exhibit little to no HIF-1α
protein, while in low oxygen exhibit abundant HIF-1α protein.

Similarly, lineage

committed SM-10 and Rcho-1 stem cell-like cells exhibit abundant HIF-1α protein levels
in low oxygen with little to no HIF-1α protein exhibited in 21% oxygen. HIF-1 activity
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is regulated post translationally through protein modifications such as phosphorylation
and acetylation of the α subunit. Although significant activation of the HRE reporter was
observed in all three cell lines in low oxygen, variability in reporter activation is observed
between the TS, Rcho-1 and SM-10 cell lines. This variation may be attributed to the
differences between states of differentiation. While TS cells are true stem cells, which
have been shown to recolonize the mouse placenta, the Rcho-1 and SM-10 cells exhibit a
more lineage committed state (105,106,112,122). The TS and SM-10 cells have been
isolated from mice whereas the Rcho-1 cells have been isolated from a rat
choriocarcinoma, these differences in species may also contribute to the difference in the
HIF-1α activity observed. However consistently in all the three cell lines low oxygen
induced HIF-1α protein and activity and inhibition of differentiation was observed
independent of lineage.

Prolonged HIF-1α expression in trophoblast giant cells:
The trophoblast lineage-specific, Rcho-1 HIF-1α-3xSDM clonal cell lines provide
unique opportunities to investigate the role of HIF-1α during the early phases of invasive
trophoblast differentiation. The HIF-1α-3XSDM-expressing clones exhibited significantly
higher amounts of HIF-1α protein compared with GFP-expressing clone. Although GFPexpressing clone G2 and HIF-1α3XSDM-expressing clone H2 exhibit similar levels of
HIF-1α protein, H2 expresses the oxygen insensitive form of HIF-1α, while the HIF-1α
protein observed in G2 is the endogenously expressed HIF-1α. This is further confirmed
by the PGK-1-HRE-luciferase assay. The reporter assay shows about a 1.5 fold induction
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of luciferase reporter in GFP cells when compared to clone G2, indicating the presence of
the constitutively active form of HIF.

Thus the increased expression of an oxygen

insensitive form of HIF-1α in ambient oxygen mimics the effect of low oxygen, by
inhibiting the differentiation of trophoblast cells in abundant oxygen. This study is the first
to identify HIF-1α as a master regulator of low oxygen responses in trophoblast cells.

HIF-1α and Lineage commitment:
Lineage analysis of the Rcho-1 clones expressing the constitutively active form of
HIF-1α indicates that increased HIF expression does not affect lineage commitment of
trophoblast giant cells. Previous studies in TS cells isolated from Arnt-/- and Hif-1α -/suggest a shift in lineage commitment to a predominantly labyrinthine lineage (58).
However these studies were performed in a true stem cell population. It is possible that
alterations in HIF-1α levels may affect the lineage commitment or determination step
early in the process of differentiation, and then, once committed to a specific lineage,
HIF-1α may not be able to reverse or alter this step, but exhibits a new or alternate
function through the inhibition of differentiation.

Constitutively active HIF-1α inhibits Trophoblast giant cell differentiation:
Molecular differentiation of the HIF-1α-3xSDM-expressing clonal cell lines was
performed by analyzing the expression of Id2, under conditions which normally result in
differentiation. While GFP clone G downregulated Id2 expression upon differentiation,
HIF-1α clone H2, H4 or H6 did not downregulate Id2 expression upon differentiation in
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ambient oxygen. Upregulation of Id2 has been associated with an undifferentiated cell
type (13). The results suggest that increased expression of HIF-1α in ambient oxygen is
sufficient to inhibit differentiation of trophoblast cells, mimicking the effect of low
oxygen. Since increased levels of HIF-1α protein were observed in low oxygen, it is
possible that the inhibition of trophoblast differentiation observed in low oxygen is
mediated by HIF-1α. HIF-1α knockdown in trophoblast cells will be essential to confirm
this finding. Whether the HIF-1α-induced inhibition of trophoblast differentiation is an
effect of HIF-1 regulating the expression of genes critical for differentiation remains to
be investigated. Binding sites for HIF-1 have been identified in the promoter region of
Id2; it is possible that the HIF-1 inhibits differentiation of trophoblast cells through the
upregulation of Id2 expression; however this needs further investigation (128).
Functional differentiation of trophoblast giant cells was studied by analyzing
expression of CSH1; a hormone produced by differentiated giant cells and is believed to
play an important role in fetal growth and nutrition. Rcho-1 HIF-1α-3xSDM clonal cell
lines exhibit little to no CSH1 production upon induction of differentiation in ambient
oxygen. This result is consistent with inhibition of CSH1 production by trophoblast giant
cell in low oxygen (65). While the mode of HIF-1α-induced CSH1 in unknown, the
result suggests HIF-1α-inhibits functional differentiation of trophoblast giant cells.
Finally, the morphological differentiation of trophoblast giant cells was analyzed
for the expression of palladin protein and the formation of stress fibers, both critical
events in the differentiation of giant cells that are associated with the change in
morphology. It has been previously reported that low oxygen inhibits the formation of
stress fibers and inhibits palladin protein production (12,65). The low oxygen induced
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inhibition was relieved when cells were differentiated at ambient oxygen level. Rcho-1
HIF-1α-3xSDM clonal cell lines exhibit little to no stress fiber formation upon
differentiation in ambient oxygen. Some palladin protein production was observed in
clone H2, while little to no protein was observed in clone H4 and H6 upon induction of
differentiation.

The variation in palladin production observed in the HIF-1 clones

correlates with the expression of the constitutively active form of HIF-1 protein,
suggesting a dose responsive effect. Studies suggest that HIF-1 and hypoxia inhibit stress
fiber formation through the repression of phosphoprotein VASP in several human cell
lines; while other studies suggest that chronic hypoxia increases stress fiber formation
(129-132). Although both studies suggest the involvement of HIF, the contrasting results
may be due to the use of different cell models. It is unclear whether inhibition of stress
fiber formation in trophoblast cells is due to the direct HIF-induced inhibition, or the
result of molecular inhibition of trophoblast differentiation or a combination of both.
Analysis of the morphological differentiation patterns of the Rcho-1 HIF-1α3xSDM clonal lines suggests that the inhibition of differentiation correlates with the
levels of HIF-1α exhibited by each clone. Clone H6, expresses the highest level and
activity of HIF-1α and shows a strong inhibition of differentiation at the molecular and
morphological level as well as of functional differentiation. Clones H4 and H2, express
lower levels of HIF-1α protein and activity when compared with clone H6, and exhibit
inhibition of differentiation at the molecular level; both clones exhibit an alteration in
morphology albeit without the formation of stress fibers.
The inhibition of trophoblast giant cell differentiation observed in the Rcho-1
HIF-1α-3xSDM clonal lines is supported by work in phd2 knockout mice. The absence
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of PHDs would allow for stabilization of HIFs under high oxygen levels. Phd2-/- mice
show defects in placenta formation with significantly reduced and irregular distribution
of trophoblast giant cells (102). The HIF-1α-3xSDM-expressing cell lines do not show
complete differentiation in ambient oxygen, demonstrating that HIF-1α mediates the
inhibitory effects of hypoxia on the differentiation process.

Lentiviral CA-HIF-1α generation and Blastocyst transduction:
Use of lentiviral vectors for the assessment of gene expression has been studied
extensively in several cell types (133-135).

Recent studies by Okada et.al. and

Malashieva et. al. show trophoblast-specific expression of genes through lentiviral
infection of blastocysts in mice (102,123).

The application of this technology to

investigate the role of HIFs in placental development has opened new avenues for
placental research. Lentiviral transduction of the blastocysts showed a trophoblast and
placental specific expression of GFP. The absence of V5 epitope staining in the embryo
confirms a placental specific expression of the lentivirally transduced gene. Lentiviral
infections of the embryo can be performed at stages earlier than the blastocyst, which
would then allow the expression of the foreign gene in both the embryo and the placenta
(120). This tool has great potential for analysis of tissue-specific gene targeting in vivo
in a very short time.

The use of lentivirus vectors and lentivirus-mediated gene

transduction did not exhibit deleterious effects on embryonic development.

This is

consistent with other studies with lentiviral vectors which have also revealed that the
lentiviral vectors do not adversely affect development in animal models, while allowing
for long term expression of the lentiviral constructs (131,132). Together the results
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suggest that the lentiviral vectors serve as a great tool for gene expression analysis
without long term adverse effects and sustained promoter activation.

CA-HIF-1α and placental development:
Previous results have highlighted the role of HIF-1 in trophoblasts exposed to low
oxygen and that an increase in HIF-1 expression was sufficient to inhibit the
differentiation of trophoblast giant cells under ambient oxygen conditions, mimicking
hypoxia (65).
To test the effect of placental-specific expression of HIF-1α on placental
development in vivo, blastocysts at embryonic day 3.5 were infected with lentivirus
carrying the CA-HIF-1α gene. Increased expression of the constitutively active form of
HIF-1 exhibited significant changes in placental morphology (E12.5). Although the
labyrinthine layer was the most affected, alteration in the composition of the
spongiotrophoblast layer and the distribution of the trophoblast giant cells is also evident.
pLv-[CA-HIF-1α]-V5 infected placenta exhibited pecam-1 staining in cells lining
the blood vessels in both the labyrinthine region as well as the region adjacent to the
trophoblast giant cells.

Pecam-1staining identifies the endothelial cell types; the

labyrinthine blood vessels are lined with endothelial cells, and are a result of
neovasculogenesis. The blood vessels located near the trophoblast giant cell region (near
the maternal decidua) are lined by the invading trophoblast giant cells, as they invade and
remodel maternal arteries during implantation. The presence of pecam-1 staining in the
maternal blood spaces indicates incomplete remodeling of the maternal arteries. This
also suggests decreased invasion of the maternal arteries by the trophoblast giant cells.
111

Invasion and maternal arterial remodeling is a function of differentiated TGCs, thus the
result also suggests a decreased differentiation of the invading TGCs.
Gcm1 staining of the pLv-[CA-HIF-1α]-V5 infected placenta demonstrates
decreased staining in the labyrinthine region when compared to pLv-[GFP]-V5-infected
placenta. Gcm1 is a labyrinthine lineage-specific marker. Decreased Gcm1 staining
suggests a decrease in the cells committed to the labyrinthine lineage. Loss of HIF-1
results in the shift of trophoblast lineage commitment to a predominantly labyrinthine
lineage (58).

Previous studies suggest that HIF-1α expression may inhibit the

differentiation of trophoblast cells into the labyrinthine lineage. Consistent with these
studies, decreased expression of Gcm1 in the CA-HIF-1α-infected placenta suggest that
prolonged HIF-1α expression inhibits commitment of the stem cell to a labyrinthine
lineage. The labyrinthine layer allows for nutrient and waste exchange between the baby
and the mother. Decreased differentiation of the labyrinthine cells suggests decreased
labyrinthine layer functioning allowing for lower nutrient and waste exchange between
the mother and the embryo. Decreased labyrinthine layer functioning is a hallmark of
placentas obtained from IUFGR babies.
Analysis of Tpbpa/4311 and prl3b1 expression suggests a decreased penetration
of both cell types into the labyrinthine layer. Tpbpa/4311expressing cells are known to
belong to the spongiotrophoblast lineage of trophoblast cells. Spongiotrophoblast cells
are known to regulate maternal-fetal exchange and produce hormones for the
maintenance of a healthy pregnancy.

In addition to their contribution to placental

function, spongiotrophoblast cells are also known to act as precursors to the secondary
giant cell population (58).

Thus it is possible that decreased penetration of the
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prl3b1cells in the labyrinthine layer occurs due to decreased Tpbpa/4311 expressing cells
in the labyrinth.

Previous reports have shown that loss of HIF-1 alters lineage

commitment of trophoblast stem cells, allowing for commitment to only the labyrinthine
lineage. It is possible that while the presence of HIF-1 in the early stages is required for
the commitment to the spongiotrophoblast lineage, prolonged expression of HIF-1
inhibits complete differentiation into a functional cell type. Although Tpbpa/4311 has
been identified as a spongiotrophoblast marker, recent studies have identified
spongiotrophoblast subpopulations lacking Tpbpa/4311 expression (26).

The

contribution of these populations to placental development and giant cell formations need
further investigation.
Several subtypes of trophoblast giant cells have recently been identified (26). Pl2
expression is observed in the TGCs after E11.5. In the mature placenta, within the
labyrinthine region, Pl2 expression is restricted to the mononuclear giant cells that line
the maternal arteries. TGCs derived from both Tpbpa/4311 positive as well as negative
spongiotrophoblast cells exhibit Pl2 expression (26). Decreased penetration of the Pl2
positive cells in the labyrinth region could arise due to decrease in the Tpbpa/4311+ cells,
Tpbpa/4311- cells or a combination of both.

This however will need further

investigation.
Together the results from the pLv-[CA-HIF-1α]-V5-infected placentas suggest
significant alteration in placental morphology, possibly due to decreased differentiation
of the stem cells into lineage committed cell populations. The most striking finding is the
increased staining for Pecam1 (endothelial cells) in the maternal arteries.

During

placental development, the giant cells invade and remodel maternal arteries to allow for
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increased blood flow to the placenta and thus to the developing fetus. Pecam1staining in
the arteries suggest decreased giant cell differentiation, thus leading to decreased invasion
of the maternal arteries by the trophoblast giant cells, which suggests decreased maternal
artery remodeling, a hallmark feature of the human preeclamptic placenta (74,88). In
addition to decreased giant cell differentiation, alteration in the spongiotrophoblast and
giant cells is also observed. Thus our model suggests that prolonged expression of HIF1α may serve as a trigger for the initiation of preeclampsia.
Mice lacking pVHL, a protein involved in the degradation of HIF, die in utero
between E10.5-12.5 and exhibit gross deformities in both placenta as well as the embryo
formation particularly, showing hemorrhaging and necrotic lesion formation in the
labyrinthine region of the placenta. A less severe phenotype was observed in VHLinactivated embryos (99, 100). Loss of VHL would lead to prolonged HIF activity.
While HIF-1α and HIF-2α have been identified as its predominant targets, pVHL
regulates the expression of several other HIF-1-independent genes involved in signaling,
transcription, cell modeling etc, which may play a role during early embryogenesis (101).
Thus, in agreement with our study, a more severe phenotype would be expected in Vhl-/mice.

The early embryonic lethality observed in Vhl-/- mice is likely due to the

deregulation of HIF-1 as well as several proteins involved in critical cellular pathways
such as cell cycle regulation, and apoptosis.
PHD2 knockout mice would represent a condition similar to low oxygen, with
decreased HIF-1 degradation, allowing for prolonged HIF-1 activity.

Altered

spongiotrophoblast and trophoblast giant cell distribution were observed on E11.5 in
Phd2-/- placenta (102).

Our results show similar alterations in cell distribution.
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Although similarity exists between the two models, the presence of 2 other isoforms of
PHD and other mechanisms of HIF-1 degradation may possibly decrease the severity of
HIF-1-induced developmental defects observed in Phd2-/- mice. Through the direct
prolonged expression of HIF-1, our model provides a more accurate representation of the
effect of increased HIF expression on development (102). In addition, to placental
defects observed in Phd 2-/- mice, significant defects in embryonic vasculature were also
observed, suggesting a possibility of increased fetal oxygen extraction/ consumption from
the placenta. This in turn would further alter placental-fetal oxygen exchange making the
placenta more hypoxic, thus affecting placental formation/ functioning. Expression of
HIF-1 solely in the placenta allows for a better model system to study placental driven
embryonic defects.
Increased HIF-1 expression has been observed in placentas obtained from
preeclamptic women (74,79,81,136).

This increase in HIF expression has been

associated with several factors including, local decrease in oxygen tension and alteration
in the HIF degradation mechanism (72,79).

Mice with a deficiency in catecho-O-

methlytransferase (COMT), an enzyme involved in metabolism of 2-methoxyestradiol (2ME), exhibit characteristics similar to the preeclamptic women, including preterm
delivery and decreased blood pressure and proteinuria (89). 2-ME is known to suppress
HIF-1α expression in vivo, and significantly increased HIF-1 protein levels are observed
in Comt-/- placenta (89,137). This observation supports our findings that prolonged HIF1 expression may lead to a preeclamptic placental phenotype.
Since the placenta is of embryonic origin, developing from the trophoblast of the
early embryo, it is unlikely that prolonged HIF-1 expression may be restricted to the
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placenta, but may infact affect the developing embryo as well. Our model suggests that a
preeclamptic placental phenotype occurs due to prolonged HIF-1 expression in the
placenta alone.

Our model represents a condition where the placenta generates a

localized HIF-1 response allowing for prolonged HIF-1 expression beyond its normal
occurrence in the placenta.

Preeclampsia is believed to be a response to localized

placental stress (Reviewed in 70,138,139). Studies suggest that localized placental stress
could occur due to several factors including presence of pro-inflammatory cytokines,
increased insulin and IGF etc. which have been shown to up regulate HIF-1 expression.
Thus our model of placenta-specific HIF-1 is an accurate representation of the
pathogenesis of preeclampsia.
Our study suggests that placental-specific prolonged HIF-1 expression serves as a
model for the development of preeclampsia, giving rise to both placental defects similar
to those observed in human preeclamptic placentas. The study also identifies HIF-1 as a
master regulator of the hypoxic response in placental development, and suggests that
HIF-1 regulated genes may play an important role in the differentiation of functional
trophoblast cells. The role of HIF-1 in the inhibition of differentiation of several cell
types has been suggested. The ubiquitous HIF-1 signaling pathway has been shown to be
activated by stimuli independent of hypoxia in several cell types. Recent studies have
identified a cross talk between the HIF-1 and Notch signaling pathways, which is
believed to maintain cells in a stem state (140).
Although this study provides evidence for the significance of the placenta during
development, whether all the placental lineages contribute to the observed pathology
remains to be answered. Further studies elucidating the role of HIFs in specific lineages
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of the placenta may provide better insight into the contribution of placental cell types
during development.
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Summary of Findings:
¾ Low oxygen inhibits trophoblast differentiation.
¾ Low oxygen-induced inhibition of trophoblast differentiation in not specific to a
lineage.
¾ Trophoblast cells that show inhibition of differentiation in low oxygen exhibit
high levels of active, HIF-1α protein.
¾ Inhibition of trophoblast differentiation correlates with levels of active, HIF-1α
protein; cells expressing high levels of active, HIF-1α protein exhibit inhibition of
differentiation.
¾ Expression of the oxygen insensitive form of HIF-1α protein inhibits molecular,
morphological and functional differentiation of trophoblast giant cells in ambient
oxygen conditions.
¾ Expression of the oxygen insensitive form of HIF-1α protein in ambient oxygen
mimics the effect of low oxygen on trophoblast differentiation.
¾ Results suggest HIF-1α is the master regulator of effects of low oxygen on
trophoblast differentiation.
¾ Lentiviral transduction of day 3.5 p.c. blastocyst results in trophoblast-specific
transgene expression.
¾ Prolonged placental expression of the oxygen insensitive form of HIF-1α affects
placental morphology cell distribution.
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¾ Alterations in placental morphology observed in placenta exhibiting prolonged
expression of the oxygen insensitive form of HIF-1α mimic the pathology of two
pregnancy-related conditions in humans, preeclampsia and IUGR.
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Future Studies
The current study has opened up several new avenues for the roles of HIFs and
HIF-regulated factors in placental research.
Low oxygen regulates genes both in a HIF-1-dependent and a HIF-1-independent
manner. Since prolonged exposure to low oxygen and prolonged HIF-1 expression have
similar effects on the trophoblast differentiation, it is possible that HIF-1-dependent
genes regulate the inhibition of trophoblast differentiation; this is supported by the results
from the current study, where prolonged expression of the HIF-1α was sufficient to
inhibit trophoblast differentiation in ambient oxygen. To identify the genes involved in
the inhibition process, comparative microarray analysis of the gene expression patterns in
Rcho-1 HIF-1α-3XSDM clone cell lines with the GFP-expressing clone can be
performed. Genes exhibiting significant upregulation or downregulation can then be
chosen for further analysis.
Our study suggests prolonged HIF-1 expression in placenta gives rise to a
placental phenotype similar to that observed in preeclampsia. In humans, preeclampsia is
diagnosed in the third trimester. Whether preeclampsia is the result of physiological
alterations that occur during the third trimester or at an earlier time is unknown. To test
this more accurately, a placental specific-tetracycline inducible-HIF-1α (TET-inducibleHIF-1α) construct expression may be employed. Induction of placental-specific TET-
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inducible-HIF-1α at specific stages during pregnancy or on specific embryonic days may
help identify the developmental stage critical for the onset of preeclampsia.
Placental-lineage specific gene targeting can be carried out to determine the role
of each of the three placental lineages in the development of preeclampsia and other
pregnancy related disorders. In mice models, CSH2 (PL2) is expressed in trophoblast
giant cells throughout pregnancy.

Generation of a CSH2 promoter driven-HIF-1α

construct will aid in the selective expression of HIF-1α in the trophoblast giant cells.
This will help determine the effect of prolonged HIF-1α in giant cells on the
development of the placenta. Similarly the generation of a 4311/tpbpa promoter driven
HIF-1α construct and the hCYP19 promoter driven HIF-1α construct will allow selective
expression of HIF-1α in the spongiotrophoblast and the labyrinthine cell respectively.
The promoter-specific expression can be extended to studies in the embryo as well.
Lentiviral infection of the embryo at the 2-cell or 8-cell stages would transduce the
foreign gene into both the embryo as well as the placenta allowing for a direct analysis of
effect of several genes in the embryo. This method has significant advantages when
compared with traditional transgenic models, allowing for generation of transgenic
animals in a very short time span (weeks) compared to traditional methods (monthsyears).
The ubiquitous HIF-1 signaling pathway has been shown to be activated by
stimuli independent of hypoxia in several cell types. Recent studies have identified a
cross talk between the HIF-1 and Notch signaling pathway, which is believed to maintain
cells in a stem state. A direct interaction between the intracellular domain (ICD) of
Notch and HIF-1 has been observed in cells of myogenic origin (154). This interaction
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is believed to stabilize Notch-ICD, allowing for Notch-induced gene expression.
Interestingly Notch activation has been shown to preferentially regulate the lineage
determination of embryonic stem cells into the three embryonic cell lineages, but is not
involved in trophoblast cell differentiation (152). Since the formation of the embryonic
plan occurs in low oxygen, the study of the role of hypoxia and HIFs together with Notch
in the embryonic determination of cell fates may generate valuable information on
patterning of the body plan.
The role of HIF-1 as the master regulator of the process of differentiation may
have implications for several cell systems. Hypoxia is believed to direct differentiation
of neural crest stem cells into a lineage type not observed in normoxia (153). Although
the exact role of HIFs in differentiation is unclear, HIF-1 is also believed to be involved
in the differentiation of tissues such as chondryocytes and limb mesenchyme (141,142).
The role of HIF in inhibiting the differentiation of cell types may play a critical role in
the field of cancer and tumor progression. Hypoxic niches have been suggested to
promote cell division and a more undifferentiated, proliferative cell type. Hypoxia is
believed to induce the expression of an anti-apoptotic protein survivin in tumor cells.
Increased survivin mRNA level and promoter activity are observed under hypoxia.
(143,144). Survivin plays a role not only in the inhibition of apoptosis, but is also
believed to play a significant role during cytokinesis (145,146). Increased survivin
expression is observed in 60-70% of breast, colon, prostrate and pancreatic cancers
(143,147-149). A putative HIF-1α binding site has been observed in the -82 to -85 bp
region of survivin promoter (144).

Hypoxia-dependent upregulation of survivin

expression is believed to occur through the activation of HIF-1α (150). Downregulation
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of HIF-1α expression has been shown to downregulate survivin expression (151). Taken
together these studies suggest a special role for hypoxia, HIFs and survivin in the
promotion of a proliferative phenotype and may play a role in tumor progression;
however this needs to be further investigated.
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Appendix

2-ME: 2-Methoxyestradiol
ARNT: Aryl hydrocarbon receptor nuclear translocator
CA-HIF: Constitutively active- hypoxia inducible factor
Cdx2: Caudal type homeobox transcription factor 2
CMV: Cytomegalovirus
COMT: Catechol-O-methyl transferase
CSH1: Chorionic somatomammotropin hormone-1
d.p.c: Days post coitum
ES: Embryonic stem cells
FGF4: Fibroblast growth factor 4
GCM1: Glial cell missing 1
GFP: Green Fluorescent Protein
Hand-1: Heart and Neural crest derived transcription factor 1
hCYP19: Human aromatase (cytochrome p450 family member 19)
HIFs: Hypoxia inducible factors
HIF-1α : Hypoxia inducible factor-1α
HIF-2α: Hypoxia inducible factor-2α
HIF-3α: Hypoxia inducible factor-3α
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HIF-1β: Hypoxia inducible factor-1β
HRE: Hypoxia responsive element
ICM: Inner cell mass
Id2: Inhibitor of differentiation 2/ Inhibitor of determination 2
IUGR / IUFGR: Intrauterine growth retardation/ intrauterine fetal growth restriction
KO: Knock out
Oct4: Octamer-4
p.c.: Post coitus
PBS: Phosphate buffered saline
Pecam-1: platelet/endothelial cell adhesion molecule-1
PGK-1: Phosphoglycerate kinase-1
PHD2: Prolyl hydroxylase domain protein 2/ prolyl hydroxylase 2
PL1: Placental lactogen 1
PL2 (prl3b1): Placental lactogen 1
pLV: Lentiviral plasmid
PVDF: Polyvinylidene Fluoride
SDS-PAGE: Sodium dodecyl sulfate polyacrylamide gel electrophoresis
Tec: Tyrosine kinases
TERT: telomerase reverse transcriptase
TGC: Trophoblast Giant cells
Tpbpa/ 4311: Trophoblast specific protein alpha
TS: Trophoblast stem cells
VHL: Von Hipple Lindeau Protein
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